var title_f18_49_19216="Inguinal swelling in a boy";
var content_f18_49_19216=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F83583&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F83583&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 605px\">",
"   <div class=\"ttl\">",
"    Inguinal swelling in a boy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 585px; height: 679px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    LGV: lymphogranuloma venereum.",
"    <div class=\"footnotes\">",
"     * Ultrasound should be performed.",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     Ultrasound may provide additional diagnostic information.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_49_19216=[""].join("\n");
var outline_f18_49_19216=null;
var title_f18_49_19217="Retracted tympanic membrane";
var content_f18_49_19217=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F52819&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F52819&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Retracted tympanic membrane",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 369px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    When there is a negative pressure in the middle ear cavity, the position of the tympanic membrane will be retracted.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_49_19217=[""].join("\n");
var outline_f18_49_19217=null;
var title_f18_49_19218="Testing algorithm for Lynch syndrome";
var content_f18_49_19218=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F75385&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F75385&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 644px\">",
"   <div class=\"ttl\">",
"    Testing algorithm for Lynch syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 624px; height: 608px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Proceeding with MLH1 methylation studies and",
"     <em>",
"      BRAF",
"     </em>",
"     v600E mutation analysis on tumor before germline genetic testing can be considered, particularly if the individual does not meet Revised Bethesda Guidelines.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodenberger M, Lindor NM. Lynch syndrome and MYH-associated polyposis: review and testing strategy. J Clin Gastroenterol 2011; 45:488. Copyright &copy; 2011 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_49_19218=[""].join("\n");
var outline_f18_49_19218=null;
var title_f18_49_19219="Gonococcal skin lesion";
var content_f18_49_19219=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F71303&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F71303&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Skin lesions in disseminated gonococcal infection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 351px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Typical small pustular skin lesion in a patient with disseminated gonococcal infection.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Don L Goldenberg, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_49_19219=[""].join("\n");
var outline_f18_49_19219=null;
var title_f18_49_19220="Magnesium hydroxide: Patient drug information";
var content_f18_49_19220=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Magnesium hydroxide: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/6/31847?source=see_link\">",
"     see \"Magnesium hydroxide: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?28/59/29622?source=see_link\">",
"     see \"Magnesium hydroxide: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F190917\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Fleet&reg; Pedia-Lax&trade; Chewable Tablet [OTC];",
"     </li>",
"     <li>",
"      Little Phillips'&reg; Milk of Magnesia [OTC];",
"     </li>",
"     <li>",
"      Milk of Magnesia [OTC];",
"     </li>",
"     <li>",
"      Milk of Magnesium [OTC];",
"     </li>",
"     <li>",
"      Phillips'&reg; Milk of Magnesia [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10019997\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10019999\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691793",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat hard stools (constipation).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691873",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat heartburn and upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691572",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to help growth and good health.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10019998\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702433",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to magnesium hydroxide or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10020003\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696895",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take other drugs within 1 hour of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10020004\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696432",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bad taste in your mouth. This most often goes back to normal.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10020006\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699014",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very hard stools (constipation).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10020001\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694599",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chewable tablet may be crushed and mixed with food or chewed. Do not swallow it whole.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694329",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       There is a liquid (suspension) if you cannot swallow pills. Shake well before use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696107",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Those who have feeding tubes may also use the liquid. Flush the feeding tube before and after this drug is given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695306",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Liquid may be mixed in water, if needed.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10020002\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10020007\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10020008\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12069 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.248-3A8E13EC2C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_49_19220=[""].join("\n");
var outline_f18_49_19220=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190917\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019997\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019999\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019998\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020003\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020004\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020006\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020001\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020002\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020007\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020008\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?31/6/31847?source=related_link\">",
"      Magnesium hydroxide: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?28/59/29622?source=related_link\">",
"      Magnesium hydroxide: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_49_19221="Typical facial features";
var content_f18_49_19221=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F53778&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F53778&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Typical facial features in a patient with hyperimmunoglobulin E syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 403px; height: 343px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_49_19221=[""].join("\n");
var outline_f18_49_19221=null;
var title_f18_49_19222="Classification and clinical manifestations of hypersensitivity pneumonitis (extrinsic allergic alveolitis)";
var content_f18_49_19222=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Classification and clinical manifestations of hypersensitivity pneumonitis (extrinsic allergic alveolitis)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/49/19222/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/49/19222/contributors\">",
"     Talmadge E King, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/49/19222/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/49/19222/contributors\">",
"     Kevin R Flaherty, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/49/19222/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/49/19222/contributors\">",
"     Helen Hollingsworth, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?18/49/19222/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 28, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypersensitivity pneumonitis (HP), also called extrinsic allergic alveolitis, is a complex syndrome of varying intensity, clinical presentation, and natural history rather than a single, uniform disease [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19222/abstract/1-5\">",
"     1-5",
"    </a>",
"    ]. Numerous inciting agents have been described including, but not limited to, agricultural dusts, bioaerosols, microorganisms (fungal, bacterial, or protozoal), and certain reactive chemical species [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19222/abstract/1,6,7\">",
"     1,6,7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/18/34087?source=see_link\">",
"     \"Epidemiology and causes of hypersensitivity pneumonitis (extrinsic allergic alveolitis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The classification and clinical manifestations of HP will be reviewed here. The epidemiology, causes, diagnostic criteria, and treatment of this disorder are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/18/34087?source=see_link\">",
"     \"Epidemiology and causes of hypersensitivity pneumonitis (extrinsic allergic alveolitis)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/12/1225?source=see_link\">",
"     \"Diagnosis of hypersensitivity pneumonitis (extrinsic allergic alveolitis)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/34/7719?source=see_link\">",
"     \"Treatment and prognosis of hypersensitivity pneumonitis (extrinsic allergic alveolitis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLASSIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Classically, the clinical presentations of HP have been categorized as acute, subacute, or chronic depending upon the frequency, length, and intensity of exposure and upon the duration of subsequent illness. In an attempt to address ambiguities that result from this taxonomy, several other classification schemes have been proposed (",
"    <a class=\"graphic graphic_table graphicRef61909 \" href=\"UTD.htm?28/46/29419\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19222/abstract/3,5,8,9\">",
"     3,5,8,9",
"    </a>",
"    ]. Unfortunately, none are completely satisfactory because of the great variability in the presentation and course of HP [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19222/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ACUTE HP",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute HP may follow heavy exposure to an inciting agent. It is the most classic and easily recognized form of HP, but symptoms still may be confused with a viral or bacterial infection, and patients are frequently treated initially with antibiotics [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19222/abstract/1,3\">",
"     1,3",
"    </a>",
"    ]. The course is characterized by the abrupt onset (four to six hours following exposure) of fever, chills, malaise, nausea, cough, chest tightness, and dyspnea without wheezing. Physical examination is notable for tachypnea and diffuse fine crackles. Wheezing is rarely present.",
"   </p>",
"   <p>",
"    Removal from exposure to the inciting antigen in acute HP results in subsiding of symptoms within 12 hours to several days and complete resolution of clinical and radiographic findings within several weeks. The disease may recur with reexposure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Laboratory findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory tests are of limited utility. The erythrocyte sedimentation rate and quantitative immunoglobulins are elevated in many patients. A positive rheumatoid factor, elevated C-reactive protein, and circulating immune complexes also may be found. The serum LDH may be high in acute phases of the disease and may decline as clinical indices improve. Positive precipitating IgG serum antibodies to common antigens may be demonstrated, and bronchoalveolar lavage (BAL) lymphocytosis is usually present. Arterial blood gases may show mild hypoxemia. Pulmonary function tests usually reveal a restrictive ventilatory defect during symptomatic episodes. In some cases, however, an obstructive pattern is found.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Radiographic findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;A fleeting, micronodular, interstitial pattern in the lower and middle lung zones may be identified, but the chest film is frequently normal (eg, in 10 of 11 patients in one study of biopsy proven HP) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19222/abstract/10\">",
"     10",
"    </a>",
"    ]. Thus, high resolution computed tomography (HRCT) is often required to confirm the presence of pneumonitis. However, the sensitivity of HRCT is not absolute, being abnormal in only five of 11 patients in the same series (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef59749 \" href=\"UTD.htm?0/1/23\">",
"     image 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19222/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Histopathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pathologically, acute HP is characterized by poorly formed, noncaseating interstitial granulomas or mononuclear cell infiltration in a peribronchial distribution, often with prominent giant cells (",
"    <a class=\"graphic graphic_picture graphicRef62359 graphicRef50605 graphicRef73716 \" href=\"UTD.htm?11/5/11354\">",
"     picture 1A-C",
"    </a>",
"    ). Well-formed granulomas are not commonly seen, in contrast to their frequent identification in patients with sarcoidosis. The frequency of various pathologic findings has been described in farmer's lung and is probably similar in other types of HP [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19222/abstract/11\">",
"     11",
"    </a>",
"    ]&nbsp;(",
"    <a class=\"graphic graphic_table graphicRef70307 \" href=\"UTD.htm?7/9/7324\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/12/1225?source=see_link&amp;anchor=H13#H13\">",
"     \"Diagnosis of hypersensitivity pneumonitis (extrinsic allergic alveolitis)\", section on 'Lung biopsy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     SUBACUTE OR INTERMITTENT HP",
"    </span>",
"    &nbsp;&mdash;&nbsp;Subacute HP is characterized by the gradual development of productive cough, dyspnea, fatigue, anorexia, and weight loss. Similar findings may occur in patients who suffer repeated, infrequent acute attacks of HP characterized by cough and malaise [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19222/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Clinical and laboratory findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Physical examination usually reveals tachypnea and diffuse crackles. The major laboratory abnormalities are bronchoalveolar lavage (BAL) lymphocytosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/12/1225?source=see_link&amp;anchor=H12#H12\">",
"     \"Diagnosis of hypersensitivity pneumonitis (extrinsic allergic alveolitis)\", section on 'Bronchoalveolar lavage'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pulmonary function testing may disclose restriction or a mixed pattern of both obstructive and restrictive ventilatory abnormalities. A reduction in diffusing capacity (DLCO) and mild arterial hypoxemia are usually present.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Radiographic findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;As in acute HP, the chest radiograph may be normal or show micronodular or reticular opacities (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef84024 \" href=\"UTD.htm?0/60/961\">",
"     image 2",
"    </a>",
"    ). The abnormalities are sometimes most prominent in the middle to upper lung zones. HRCT shows diffuse micronodules (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef71870 \" href=\"UTD.htm?3/31/3568\">",
"     image 3",
"    </a>",
"    ), ground-glass attenuation (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef59749 \" href=\"UTD.htm?0/1/23\">",
"     image 1",
"    </a>",
"    ), focal air trapping or emphysema, or mild fibrotic changes [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19222/abstract/13\">",
"     13",
"    </a>",
"    ]. These findings often undergo dramatic improvement when patients with subacute disease are removed from exposure and given glucocorticoids.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Histopathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pathologically, this form of HP is characterized by more well-formed, noncaseating granulomas in the interstitium, bronchiolitis with or without organizing pneumonia, and interstitial fibrosis (",
"    <a class=\"graphic graphic_picture graphicRef73426 graphicRef54489 \" href=\"UTD.htm?18/62/19434\">",
"     picture 2A-B",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/12/1225?source=see_link&amp;anchor=H13#H13\">",
"     \"Diagnosis of hypersensitivity pneumonitis (extrinsic allergic alveolitis)\", section on 'Lung biopsy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Course",
"    </span>",
"    &nbsp;&mdash;&nbsp;Removal from exposure usually results in complete resolution of findings, although glucocorticoid therapy may be required. The improvement takes longer than with the acute form of the disease (weeks to months). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/34/7719?source=see_link\">",
"     \"Treatment and prognosis of hypersensitivity pneumonitis (extrinsic allergic alveolitis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     CHRONIC PROGRESSIVE HP",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient with chronic HP may lack a history of acute episodes and usually reports the insidious onset of cough, dyspnea, fatigue, and weight loss. Digital clubbing may be seen in advanced disease and may help to predict clinical deterioration [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19222/abstract/14\">",
"     14",
"    </a>",
"    ]. Disabling and irreversible respiratory findings due to pulmonary fibrosis are characteristic, and are associated with increased mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19222/abstract/15\">",
"     15",
"    </a>",
"    ]. Differentiation from idiopathic pulmonary fibrosis (IPF) may be difficult [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19222/abstract/16,17\">",
"     16,17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    At this stage, removal from exposure usually results in only partial improvement, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    therapy is often required. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/34/7719?source=see_link\">",
"     \"Treatment and prognosis of hypersensitivity pneumonitis (extrinsic allergic alveolitis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Laboratory findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory findings are of minimal utility. BAL lymphocytosis may still be present, but other abnormalities, such as BAL neutrophilia or eosinophilia, may be seen (see below). A moderate to severe restrictive defect is common; however, mixed obstructive and restrictive physiology is often present, and an isolated severe obstructive defect can be seen. The diffusing capacity is invariably reduced, and resting or exertional hypoxemia is common. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/12/1225?source=see_link&amp;anchor=H6#H6\">",
"     \"Diagnosis of hypersensitivity pneumonitis (extrinsic allergic alveolitis)\", section on 'Serum precipitins'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Radiographic findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;The radiographic features of chronic HP often mirror those of IPF [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19222/abstract/17\">",
"     17",
"    </a>",
"    ] but, as in the other forms of HP, radiographic testing may occasionally be normal [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19222/abstract/18\">",
"     18",
"    </a>",
"    ]. The chest roentgenogram typically shows progressive fibrotic changes with loss of lung volume, particularly affecting the upper lobes. Nodular or ground glass densities are less commonly appreciated. Several studies in individuals with chronic HP suggest that emphysema (without a history of smoking or other occupational exposure) is found in up to 15 percent of persons on chest radiograph and 27 percent on HRCT [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19222/abstract/13,18\">",
"     13,18",
"    </a>",
"    ]. HRCT tends to show ground-glass attenuation and parenchymal micronodules, accompanied by honeycombing",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    emphysema (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef52041 \" href=\"UTD.htm?32/58/33711\">",
"     image 4",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19222/abstract/17\">",
"     17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/12/1225?source=see_link&amp;anchor=H8#H8\">",
"     \"Diagnosis of hypersensitivity pneumonitis (extrinsic allergic alveolitis)\", section on 'High resolution CT scan'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Diagnostic evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to a careful exposure history, diagnosis of the chronic form of HP usually requires bronchoscopy with bronchoalveolar lavage (to assess lymphocyte counts and subsets) and open or video-assisted thoracoscopic lung biopsy in order to collect adequate specimens. In addition to granulomatous pneumonitis, biopsy specimens at this stage reveal diffuse interstitial pneumonitis, bronchiolitis obliterans (with or without organizing pneumonia), and distal destruction of alveoli (honeycombing) in association with densely fibrotic zones (",
"    <a class=\"graphic graphic_picture graphicRef70392 graphicRef56574 \" href=\"UTD.htm?19/3/19512\">",
"     picture 3A-B",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19222/abstract/11\">",
"     11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/12/1225?source=see_link\">",
"     \"Diagnosis of hypersensitivity pneumonitis (extrinsic allergic alveolitis)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/36/16968?source=see_link&amp;anchor=H3#H3\">",
"     \"Role of bronchoalveolar lavage in diagnosis of interstitial lung disease\", section on 'Lymphocytic BAL'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/26/424?source=see_link\">",
"     \"Role of lung biopsy in the diagnosis of interstitial lung disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     MIMICS OF HP",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several important clinical syndromes that occur as a result of inhalation of organic agents but are not true forms of HP. Nevertheless, they are important to recognize and manage. In particular, inhalation fever, organic dust toxic syndrome, chronic bronchitis, asthma, and chronic airflow limitation have been found in patients with exposure to agricultural products, wood dust, and to a lesser extent among persons with other exposures. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/12/1225?source=see_link&amp;anchor=H15#H15\">",
"     \"Diagnosis of hypersensitivity pneumonitis (extrinsic allergic alveolitis)\", section on 'Mimics of HP'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H108316233\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Classically, the clinical presentations of hypersensitivity pneumonitis (HP) have been categorized as acute, subacute, or chronic depending upon the frequency, length, and intensity of exposure and upon the duration of subsequent illness. However, several other classification schemes have been proposed (",
"      <a class=\"graphic graphic_table graphicRef61909 \" href=\"UTD.htm?28/46/29419\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Classification'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The typical presentation of acute HP is the abrupt onset (four to six hours following exposure) of fever, chills, malaise, nausea, cough, chest tightness, and dyspnea. Physical examination shows tachypnea and diffuse fine crackles. The chest radiograph may be normal or show transient patchy, micronodular opacities. Removal from exposure to the inciting antigen, leads to improvement in symptoms and signs within 12 hours to several days and resolution within several weeks. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Acute HP'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Subacute HP is characterized by the gradual development of productive cough, dyspnea, fatigue, anorexia, and weight loss. The degree of respiratory impairment is more pronounced than with acute HP, and radiographic findings more extensive. Symptoms and signs usually resolve with removal from exposure, although more slowly than with acute HP. Systemic glucocorticoids are occasionally necessary. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Subacute or intermittent HP'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/12/1225?source=see_link\">",
"       \"Diagnosis of hypersensitivity pneumonitis (extrinsic allergic alveolitis)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/34/7719?source=see_link&amp;anchor=H7#H7\">",
"       \"Treatment and prognosis of hypersensitivity pneumonitis (extrinsic allergic alveolitis)\", section on 'Treatment'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The patient with chronic HP may lack a history of acute episodes and usually reports the insidious onset of cough, dyspnea, fatigue, and weight loss. Digital clubbing may be seen in advanced disease. Disabling and irreversible respiratory findings due to pulmonary fibrosis are characteristic and may be difficult to differentiate from idiopathic pulmonary fibrosis (IPF). In addition to a careful exposure history, open or video-assisted thoracoscopic lung biopsy is often needed to make a firm diagnosis. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Chronic progressive HP'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/12/1225?source=see_link\">",
"       \"Diagnosis of hypersensitivity pneumonitis (extrinsic allergic alveolitis)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The treatment and prognosis of HP are discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/34/7719?source=see_link\">",
"       \"Treatment and prognosis of hypersensitivity pneumonitis (extrinsic allergic alveolitis)\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19222/abstract/1\">",
"      Agostini C, Trentin L, Facco M, Semenzato G. New aspects of hypersensitivity pneumonitis. Curr Opin Pulm Med 2004; 10:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19222/abstract/2\">",
"      Selman M. Hypersensitivity pneumonitis: a multifaceted deceiving disorder. Clin Chest Med 2004; 25:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19222/abstract/3\">",
"      Cormier, Y, Lacasse, Y. Keys to the diagnosis of hypersensitivity pneumonitis: The role of serum precipitins, lung biopsy, and high-resolution computed tomography. Clin Pulm Med 1996; 3:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19222/abstract/4\">",
"      Rose C, King TE Jr. Controversies in hypersensitivity pneumonitis. Am Rev Respir Dis 1992; 145:1.",
"     </a>",
"    </li>",
"    <li>",
"     Selman M. Hypersensitivity pneumonitis. In: Interstitial Lung Disease, 4th ed, King TE Jr, Schwarz MI (Eds), B.C. Decker, Hamilton, ON, Canada 2003. p.452.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19222/abstract/6\">",
"      Yi ES. Hypersensitivity pneumonitis. Crit Rev Clin Lab Sci 2002; 39:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19222/abstract/7\">",
"      Mohr LC. Hypersensitivity pneumonitis. Curr Opin Pulm Med 2004; 10:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19222/abstract/8\">",
"      Boyd G, McSharry CP, Banham SW, Lynch PP. A current view of pigeon fancier's lung. A model for pulmonary extrinsic allergic alveolitis. Clin Allergy 1982; 12 Suppl:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19222/abstract/9\">",
"      Richerson HB, Bernstein IL, Fink JN, et al. Guidelines for the clinical evaluation of hypersensitivity pneumonitis. Report of the Subcommittee on Hypersensitivity Pneumonitis. J Allergy Clin Immunol 1989; 84:839.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19222/abstract/10\">",
"      Lynch DA, Rose CS, Way D, King TE Jr. Hypersensitivity pneumonitis: sensitivity of high-resolution CT in a population-based study. AJR Am J Roentgenol 1992; 159:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19222/abstract/11\">",
"      Reyes CN, Wenzel FJ, Lawton BR, Emanuel DA. The pulmonary pathology of farmer's lung disease. Chest 1982; 81:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19222/abstract/12\">",
"      Schlueter DP. Response of the lung to inhaled antigens. Am J Med 1974; 57:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19222/abstract/13\">",
"      Remy-Jardin M, Remy J, Wallaert B, M&uuml;ller NL. Subacute and chronic bird breeder hypersensitivity pneumonitis: sequential evaluation with CT and correlation with lung function tests and bronchoalveolar lavage. Radiology 1993; 189:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19222/abstract/14\">",
"      Sansores R, Salas J, Chapela R, et al. Clubbing in hypersensitivity pneumonitis. Its prevalence and possible prognostic role. Arch Intern Med 1990; 150:1849.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19222/abstract/15\">",
"      Vourlekis JS, Schwarz MI, Cherniack RM, et al. The effect of pulmonary fibrosis on survival in patients with hypersensitivity pneumonitis. Am J Med 2004; 116:662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19222/abstract/16\">",
"      Buschman DL, Gamsu G, Waldron JA Jr, et al. Chronic hypersensitivity pneumonitis: use of CT in diagnosis. AJR Am J Roentgenol 1992; 159:957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19222/abstract/17\">",
"      Lynch DA, Newell JD, Logan PM, et al. Can CT distinguish hypersensitivity pneumonitis from idiopathic pulmonary fibrosis? AJR Am J Roentgenol 1995; 165:807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19222/abstract/18\">",
"      Lalancette M, Carrier G, Laviolette M, et al. Farmer's lung. Long-term outcome and lack of predictive value of bronchoalveolar lavage fibrosing factors. Am Rev Respir Dis 1993; 148:216.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4312 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-219.243.220.100-9E6818F356-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_49_19222=[""].join("\n");
var outline_f18_49_19222=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H108316233\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLASSIFICATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ACUTE HP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Laboratory findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Radiographic findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Histopathology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      SUBACUTE OR INTERMITTENT HP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Clinical and laboratory findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Radiographic findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Histopathology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Course",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      CHRONIC PROGRESSIVE HP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Laboratory findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Radiographic findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Diagnostic evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      MIMICS OF HP",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H108316233\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/4312\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4312|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?0/1/23\" title=\"diagnostic image 1\">",
"      Acute EAA CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?0/60/961\" title=\"diagnostic image 2\">",
"      Acute HP chest radiograph",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?3/31/3568\" title=\"diagnostic image 3\">",
"      Subacute HP CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?32/58/33711\" title=\"diagnostic image 4\">",
"      Chronic EAA CT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4312|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?39/9/40080\" title=\"picture 1A\">",
"      HP infiltrate Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?30/12/30918\" title=\"picture 1B\">",
"      HP granulomas Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?36/44/37568\" title=\"picture 1C\">",
"      HP giant cells Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?28/39/29299\" title=\"picture 2A\">",
"      HP bronchiolitis Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?27/9/27800\" title=\"picture 2B\">",
"      Bronchiolitis obliterans Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?8/61/9171\" title=\"picture 3A\">",
"      Chronic HP Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?22/10/22691\" title=\"picture 3B\">",
"      Chronic farmers lung Light",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4312|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?28/46/29419\" title=\"table 1\">",
"      HP classification system",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?7/9/7324\" title=\"table 2\">",
"      Pulmonary biopsies in farmers",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/12/1225?source=related_link\">",
"      Diagnosis of hypersensitivity pneumonitis (extrinsic allergic alveolitis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/18/34087?source=related_link\">",
"      Epidemiology and causes of hypersensitivity pneumonitis (extrinsic allergic alveolitis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/36/16968?source=related_link\">",
"      Role of bronchoalveolar lavage in diagnosis of interstitial lung disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/26/424?source=related_link\">",
"      Role of lung biopsy in the diagnosis of interstitial lung disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/34/7719?source=related_link\">",
"      Treatment and prognosis of hypersensitivity pneumonitis (extrinsic allergic alveolitis)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_49_19223="Perphenazine: Drug information";
var content_f18_49_19223=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Perphenazine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?11/50/12069?source=see_link\">",
"    see \"Perphenazine: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?10/6/10343?source=see_link\">",
"    see \"Perphenazine: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F7290569\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information. For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F208621\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Perphenazine&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F208654\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antiemetic;",
"     </li>",
"     <li>",
"      Antipsychotic Agent, Typical, Phenothiazine",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F208625\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Schizophrenia:",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Nonhospitalized: Initial: 4-8 mg 3 times/day; reduce dose as soon as possible to minimum effective dosage (maximum: 24 mg/day)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hospitalized: 8-16 mg 2-4 times/day (maximum: 64 mg/day)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Nausea/vomiting:",
"     </b>",
"     Oral: 8-16 mg/day in divided doses; reduce dose as soon as possible to minimum effective dosage (maximum: 24 mg/day)",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F208626\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling; however, initiate dosing at the lower end of the dosing range. Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F208627\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     0% to 5% removed by hemodialysis (HD); no dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F208628\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F208600\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: 2 mg, 4 mg, 8 mg, 16 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F208585\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F13706647\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;\">",
"     May be administered without regard to meals.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F208604\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of schizophrenia; severe nausea and vomiting",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F208651\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Psychosis; psychosis/agitation related to Alzheimer's dementia (risks vs benefits)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F208662\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Trilafon may be confused with Tri-Levlen&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      BEERS Criteria medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This drug may be potentially inappropriate for use in geriatric patients (Quality of evidence - moderate; Strength of recommendation - strong).",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F208652\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Bradycardia, cardiac arrest, ECG changes, hyper-/hypotension, orthostatic hypotension, pallor, peripheral edema, sudden death, tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Bizarre dreams, catatonic-like states, cerebral edema, dizziness, drowsiness, extrapyramidal symptoms (pseudoparkinsonism, akathisia, dystonias, tardive dyskinesia), faintness, headache, hyperactivity, hyperpyrexia, impairment of temperature regulation, insomnia, lethargy, neuroleptic malignant syndrome (NMS), nocturnal confusion, paradoxical excitement, paranoid reactions, restlessness, seizure",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Discoloration of skin (blue-gray), photosensitivity",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Amenorrhea, breast enlargement, hyper-/hypoglycemia, galactorrhea, lactation, libido changes, gynecomastia, menstrual irregularity, parotid swelling (rare), SIADH",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Adynamic ileus, anorexia, appetite increased, constipation, diarrhea, fecal impaction, obstipation, nausea, salivation, vomiting, weight gain, xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Bladder paralysis, ejaculatory disturbances, incontinence, polyuria, urinary retention",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Agranulocytosis, eosinophilia, hemolytic anemia, leukopenia, pancytopenia, thrombocytopenic purpura",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Hepatotoxicity, jaundice",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Muscle weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Blurred vision, cornea and lens changes, epithelial keratopathies, glaucoma, mydriasis, myosis, photophobia, pigmentary retinopathy",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Renal: Glycosuria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Nasal congestion",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Allergic reactions, diaphoresis, systemic lupus erythematosus-like syndrome",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F208607\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to perphenazine or any component of the formulation (cross-reactivity between phenothiazines may occur); severe CNS depression (comatose or patients receiving large doses of CNS depressants); subcortical brain damage (with or without hypothalamic damage); bone marrow suppression; blood dyscrasias; liver damage",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F208589\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Altered cardiac conduction: May alter cardiac conduction (life-threatening arrhythmias have occurred with therapeutic doses of phenothiazines).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Anticholinergic effects: May cause anticholinergic effects (constipation, xerostomia, blurred vision, urinary retention); use with caution in patients with decreased gastrointestinal motility, paralytic ileus, urinary retention, BPH, xerostomia, or visual problems. Relative to other neuroleptics, perphenazine has a low potency of cholinergic blockade.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Blood dyscrasias: Leukopenia, neutropenia, and agranulocytosis (sometimes fatal) have been reported in clinical trials and postmarketing reports with antipsychotic use; presence of risk factors (eg, pre-existing low WBC or history of drug-induced leuko-/neutropenia) should prompt periodic blood count assessment. Discontinue therapy at first signs of blood dyscrasias or if absolute neutrophil count &lt;1000/mm",
"     <sup>",
"      3",
"     </sup>",
"     .",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Esophageal dysmotility/aspiration: Antipsychotic use has been associated with esophageal dysmotility and aspiration; use with caution in patients at risk of pneumonia (eg, Alzheimer's disease).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Extrapyramidal symptoms (EPS): May cause extrapyramidal symptoms, including pseudoparkinsonism, acute dystonic reactions, akathisia, and tardive dyskinesia. Risk of dystonia (and possibly other EPS) may be greater with increased doses, use of conventional antipsychotics, males, and younger patients. Risk of tardive dyskinesia and potential for irreversibility often associated with total cumulative dose and therapy duration and may also be increased in elderly patients (particularly elderly women); antipsychotics may also mask signs/symptoms of tardive dyskinesia.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hyperprolactinemia: Use associated with increased prolactin levels; clinical significance of hyperprolactinemia in patients with breast cancer or other prolactin-dependent tumors is unknown.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Neuroleptic malignant syndrome (NMS): May be associated with NMS; monitor for mental status changes, fever, muscle rigidity, and/or autonomic instability.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Ocular effects: May cause pigmentary retinopathy, and lenticular and corneal deposits, particularly with prolonged therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Orthostatic hypotension: May cause orthostatic hypotension; use with caution in patients at risk of this effect or in those who would not tolerate transient hypotensive episodes (cerebrovascular disease, cardiovascular disease, hypovolemia, or concurrent medication use which may predispose to hypotension/bradycardia).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Photosensitivity: May cause photosensitization; avoid prolonged exposure to sunlight.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sedation: May cause sedation, which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Temperature regulation: Impaired core body temperature regulation may occur; caution with strenuous exercise, heat exposure, dehydration, and concomitant medication possessing anticholinergic effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular disease: Use with caution in patients with severe cardiovascular disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Dementia:",
"     <b>",
"      [U.S. Boxed Warning]: Elderly patients with dementia-related psychosis treated with antipsychotics are at an increased risk of death compared to placebo.",
"     </b>",
"     Most deaths appeared to be either cardiovascular (eg, heart failure, sudden death) or infectious (eg, pneumonia) in nature. Perphenazine is not approved for the treatment of dementia-related psychosis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Depression: Use with caution in patients with depression; possibility of increased risk of suicide; limit quantities of drug available until significant remission observed.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Glaucoma: Use with caution in patients with narrow-angle glaucoma; condition may be exacerbated by cholinergic blockade.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Monitor hepatic function during use; discontinue if abnormalities occur; contraindicated in patients with liver damage.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Myasthenia gravis: Use with caution in patients with myasthenia gravis; condition may be exacerbated by cholinergic blockade.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Parkinson's disease: Use with caution in patients with Parkinson's disease; they may be more sensitive to adverse effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment. Monitor renal function during therapy; discontinue if BUN abnormalities occur.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Respiratory disease: Use with caution in patients with respiratory disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Seizure disorder: Use with caution in patients at risk of seizures, including those with a history of seizures, head trauma, brain damage, alcoholism, or concurrent therapy with medications which may lower seizure threshold.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Antiemetic effects: May mask toxicity of other drugs or conditions (eg, intestinal obstruction, Reye's syndrome, brain tumor) due to antiemetic effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sedatives: Effects may be potentiated when used with other sedative drugs or ethanol.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Use in patients with dementia is associated with an increased risk of mortality and cerebrovascular accidents; avoid antipsychotic use for behavioral problems associated with dementia unless alternative nonpharmacologic therapies have failed and patient may harm self or others. In addition, use may cause or exacerbate syndrome of inappropriate antidiuretic hormone secretion or hyponatremia; monitor sodium closely with initiation or dosage adjustments in older adults. May also be inappropriate in older adults depending on comorbidities (eg, dementia, delirium) due to its potent anticholinergic effects (Beers Criteria). Potential for an increased risk of adverse events (eg, sedation, orthostatic hypotension, anticholinergic effects) and an increased risk for developing tardive dyskinesia, particularly in elderly women.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Poor metabolizers: Use with caution in patients with reduced functional alleles of CYP2D6. Poor metabolizers may have higher plasma concentrations at usual doses, increasing risk for adverse reactions.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F208649\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP1A2 (minor), CYP2C19 (minor), CYP2C9 (minor), CYP2D6 (major), CYP3A4 (minor);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP1A2 (weak), CYP2D6 (weak)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F208594\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Abiraterone Acetate: May increase the serum concentration of CYP2D6 Substrates. Management: Avoid concurrent use of abiraterone with CYP2D6 substrates that have a narrow therapeutic index whenever possible.  When concurrent use is not avoidable, monitor patients closely for signs/symptoms of toxicity.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetylcholinesterase Inhibitors (Central): May enhance the neurotoxic (central) effect of Antipsychotics. Severe extrapyramidal symptoms have occurred in some patients.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aclidinium: May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: Antipsychotics may diminish the stimulatory effect of Amphetamines.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Analgesics (Opioid): Antipsychotic Agents (Phenothiazines) may enhance the hypotensive effect of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antacids: May decrease the absorption of Antipsychotic Agents (Phenothiazines).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticholinergics: May enhance the adverse/toxic effect of other Anticholinergics.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antidepressants (Serotonin Reuptake Inhibitor/Antagonist): Antipsychotic Agents (Phenothiazines) may enhance the adverse/toxic effect of Antidepressants (Serotonin Reuptake Inhibitor/Antagonist). Specifically, this may be manifest as symptoms consistent with serotonin syndrome or neuroleptic malignant syndrome. Antidepressants (Serotonin Reuptake Inhibitor/Antagonist) may enhance the hypotensive effect of Antipsychotic Agents (Phenothiazines).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antimalarial Agents: May increase the serum concentration of Antipsychotic Agents (Phenothiazines).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anti-Parkinson's Agents (Dopamine Agonist): May diminish the therapeutic effect of Antipsychotics (Typical). Antipsychotics (Typical) may diminish the therapeutic effect of Anti-Parkinson's Agents (Dopamine Agonist). Management: Avoid concomitant therapy if possible and monitor for decreased effects of both agents when these combinations cannot be avoided. Atypical antipsychotics such as clozapine and quetiapine may be less likely to reduce the effects of anti-Parkinson's agents.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP2D6 Inhibitors (Weak) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta-Blockers: Antipsychotic Agents (Phenothiazines) may enhance the hypotensive effect of Beta-Blockers. Beta-Blockers may decrease the metabolism of Antipsychotic Agents (Phenothiazines). Antipsychotic Agents (Phenothiazines) may decrease the metabolism of Beta-Blockers.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Atenolol; Levobunolol; Metipranolol; Nadolol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2D6 Inhibitors (Moderate): May decrease the metabolism of CYP2D6 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2D6 Inhibitors (Strong): May decrease the metabolism of CYP2D6 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Darunavir: May increase the serum concentration of CYP2D6 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ipratropium (Oral Inhalation): May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lithium formulations: May enhance the neurotoxic effect of Antipsychotics. Lithium formulations may decrease the serum concentration of Antipsychotics. Specifically noted with chlorpromazine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrimeprazine: CNS Depressants may enhance the CNS depressant effect of Methotrimeprazine. Methotrimeprazine may enhance the CNS depressant effect of CNS Depressants.  Management: Reduce adult dose of CNS depressant agents by 50% with initiation of concomitant methotrimeprazine therapy. Further CNS depressant dosage adjustments should be initiated only after clinically effective methotrimeprazine dose is established.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methylphenidate: Antipsychotics may enhance the adverse/toxic effect of Methylphenidate. Methylphenidate may enhance the adverse/toxic effect of Antipsychotics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metoclopramide: May enhance the adverse/toxic effect of Antipsychotics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: May enhance the adverse/toxic effect of Antipsychotics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Peginterferon Alfa-2b: May decrease the serum concentration of CYP2D6 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Porfimer: Photosensitizing Agents may enhance the photosensitizing effect of Porfimer.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramlintide: May enhance the anticholinergic effect of Anticholinergics. These effects are specific to the GI tract.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Quinagolide: Antipsychotics may diminish the therapeutic effect of Quinagolide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Serotonin Modulators: Antipsychotics may enhance the serotonergic effect of Serotonin Modulators. This could result in serotonin syndrome.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tetrabenazine: May enhance the adverse/toxic effect of Antipsychotics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tiotropium: Anticholinergics may enhance the anticholinergic effect of Tiotropium.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F208618\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ethanol: May increase CNS depression; monitor for increased effects with coadministration. Caution patients about effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Herb/Nutraceutical: Avoid kava kava, gotu kola, valerian, St John's wort (may increase CNS depression).",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F10949611\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Jaundice or hyper/hyporeflexia have been reported in newborn infants following maternal use of phenothiazines. Antipsychotic use during the third trimester of pregnancy has a risk for abnormal muscle movements (extrapyramidal symptoms [EPS]) and withdrawal symptoms in newborns following delivery. Symptoms in the newborn may include agitation, feeding disorder, hypertonia, hypotonia, respiratory distress, somnolence, and tremor; these effects may be self-limiting or require hospitalization.",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F10949612\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Based on information from two mother-infant pairs, following maternal use of perphenazine 16-24 mg/day, the estimated exposure to the breast-feeding infant would be 0.1% to 0.2% of the weight-adjusted maternal dose. Adverse events have not been reported in nursing infants (information from four cases). Infants should be monitored for signs of adverse events; routine monitoring of infant serum concentrations is not recommended.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F208609\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Perphenazine Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2 mg (100): $87.29",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     4 mg (100): $119.48",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     8 mg (100): $144.91",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     16 mg (100): $184.29",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F208598\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Vital signs; lipid profile, fasting blood glucose/Hgb A",
"     <sub>",
"      1c",
"     </sub>",
"     , liver and kidney function (periodically during therapy), CBC (prior to and periodically during therapy); BMI; mental status, abnormal involuntary movement scale (AIMS), extrapyramidal symptoms (EPS)",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F208601\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     2-6 nmol/L",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F208610\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Animin (TW);",
"     </li>",
"     <li>",
"      APO-Perphenazine (MY);",
"     </li>",
"     <li>",
"      Decentan (AT, DE, ES);",
"     </li>",
"     <li>",
"      Fentazin (GB, IE);",
"     </li>",
"     <li>",
"      Leptopsique (MX);",
"     </li>",
"     <li>",
"      Peratsin (FI);",
"     </li>",
"     <li>",
"      Pernamed (TH);",
"     </li>",
"     <li>",
"      Pernazine (TH);",
"     </li>",
"     <li>",
"      Perphenan (IL);",
"     </li>",
"     <li>",
"      Porazine (TH);",
"     </li>",
"     <li>",
"      Trilafon (BE, CH, DK, ID, IT, LU, NL, NO, PL, SE);",
"     </li>",
"     <li>",
"      Trilifan (FR);",
"     </li>",
"     <li>",
"      Trimin (AE, BH, CY, EG, IL, IQ, IR, JO, KP, KW, LB, LY, OM, QA, SA, SY, YE)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F208588\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Perphenazine is a piperazine phenothiazine antipsychotic which blocks postsynaptic mesolimbic dopaminergic receptors in the brain; exhibits alpha-adrenergic blocking effect and depresses the release of hypothalamic and hypophyseal hormones",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F208606\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Oral: Well absorbed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Extensively hepatic to metabolites via sulfoxidation, hydroxylation, dealkylation, and glucuronidation; primarily metabolized by CYP2D6 to N-dealkylated perphenazine, perphenazine sulfoxide, and 7-hydroxyperphenazine (active metabolite with 70% of the activity of perphenazine)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Perphenazine: 9-12 hours; 7-hydroxyperphenazine: 10-19 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, serum: Perphenazine: 1-3 hours; 7-hydroxyperphenazine: 2-4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine and feces",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Academy of Pediatrics Committee on Drugs, \"Transfer of Drugs and Other Chemicals Into Human Milk,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2001, 108(3):776-89.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/49/19223/abstract-text/11533352/pubmed\" id=\"11533352\" target=\"_blank\">",
"        11533352",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      American Geriatrics Society 2012 Beers Criteria Update Expert Panel, \"American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults,\"",
"      <i>",
"       J Am Geriatr Soc",
"      </i>",
"      , 2012, 60(4):616-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/49/19223/abstract-text/22376048/pubmed\" id=\"22376048\" target=\"_blank\">",
"        22376048",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Azaz-Livshits TL, Symmer LI, and Fraenkel YM, &ldquo;Atypical Neuroleptic Malignant Syndrome Presenting as Rhabdomyolysis, Altered Consciousness, and Leukocytosis,&rdquo;",
"      <i>",
"       J Pharm Technol",
"      </i>",
"      , 1995, 11:173-5.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Fortinguerra F, Clavenna A, and Bonati M, \"Psychotropic Drug Use During Breastfeeding: A Review of the Evidence,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2009, 124(4):e547-56.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/49/19223/abstract-text/19736267/pubmed\" id=\"19736267\" target=\"_blank\">",
"        19736267",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gill SS, Bronskill SE, Normand SL, et al, &ldquo;Antipsychotic Drug Use and Mortality in Older Adults With Dementia,&rdquo;",
"      <i>",
"       Ann Intern Med",
"      </i>",
"      , 2007, 146(11):775-86.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/49/19223/abstract-text/17548409/pubmed\" id=\"17548409\" target=\"_blank\">",
"        17548409",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hansen LB and Larsen NE, &ldquo;Metabolic Interaction Between Perphenazine and Disulfiram,&rdquo;",
"      <i>",
"       Lancet",
"      </i>",
"      , 1982, 2(8313):1472.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Harper G, Dawes M, Azlin C, et al, &ldquo;Small Bowel Obstruction in a Child on an Antipsychotic,&rdquo;",
"      <i>",
"       J Child Adolesc Psychopharmacol",
"      </i>",
"      , 1995, 5:81-4.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lieberman JA, Stroup TS, McEvoy JP, et al, &ldquo;Effectiveness of Antipsychotic Drugs in Patients With Chronic Schizophrenia,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2005, 353(12):1209-23.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/49/19223/abstract-text/16172203/pubmed\" id=\"16172203\" target=\"_blank\">",
"        16172203",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Moore TA, &ldquo;Schizophrenia Treatment Guidelines in the United States,&rdquo;",
"      <i>",
"       Clin Schizophr Relat Psychoses",
"      </i>",
"      , 2011, 5(1):40-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/49/19223/abstract-text/21459738/pubmed\" id=\"21459738\" target=\"_blank\">",
"        21459738",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Institute for Health and Clinical Excellence (NICE), National Collaborating Centre for Mental Health , &ldquo;Schizophrenia. Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care (Updated),&rdquo; National Clinical Practice Guideline Number 82, 2009:1-399. Available at  www.nice.org.uk/cg082",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rabins PV, Blacker D, Rovner BW, et al, &ldquo;American Psychiatric Association Practice Guideline for the Treatment of Patients With Alzheimer's Disease and Other Dementias. Second Edition,&rdquo;",
"      <i>",
"       Am J Psychiatry",
"      </i>",
"      , 2007, 164(12 Suppl):5-56.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/49/19223/abstract-text/18340692/pubmed\" id=\"18340692\" target=\"_blank\">",
"        18340692",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Schneeweiss S, Setoguchi S, Brookhart A, et al, &ldquo;Risk of Death Associated With the Use of Conventional Versus Atypical Antipsychotic Drugs Among Elderly Patients,&rdquo;",
"      <i>",
"       CMAJ",
"      </i>",
"      , 2007, 176(5): 627-32.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/49/19223/abstract-text/17325327/pubmed\" id=\"17325327\" target=\"_blank\">",
"        17325327",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Seifert RD, &ldquo;Therapeutic Drug Monitoring: Psychotropic Drugs,&rdquo;",
"      <i>",
"       J Pharm Pract",
"      </i>",
"      , 1984, 6:403-16.",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9760 Version 44.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-217.117.136.88-C2C11C53A9-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_49_19223=[""].join("\n");
var outline_f18_49_19223=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7290569\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208621\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208654\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208625\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208626\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208627\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208628\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208600\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208585\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13706647\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208604\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208651\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208662\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208652\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208607\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208589\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208649\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208594\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208618\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10949611\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10949612\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208609\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208598\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208601\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208610\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208588\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208606\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9760\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9760|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?11/50/12069?source=related_link\">",
"      Perphenazine: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?10/6/10343?source=related_link\">",
"      Perphenazine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_49_19224="Grade III infiltrating ductal carcinoma of the breast";
var content_f18_49_19224=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F67082&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F67082&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 603px\">",
"   <div class=\"ttl\">",
"    Grade III infiltrating ductal carcinoma of the breast",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 583px; height: 230px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (Panel A) Low power view of a poorly differentiated breast carcinoma shows that the tumor is composed of solid nests of neoplastic cells without evidence of gland formation.",
"    <br/>",
"    (Panel B) The high power view demonstrates marked nuclear atypia in the tumor cells with considerable mitotic activity.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Stuart Schnitt, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_49_19224=[""].join("\n");
var outline_f18_49_19224=null;
var title_f18_49_19225="Urea cycle disorders: Management";
var content_f18_49_19225=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Urea cycle disorders: Management",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/49/19225/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/49/19225/contributors\">",
"     Brendan Lee, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/49/19225/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/49/19225/contributors\">",
"     Joseph A Garcia-Prats, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/49/19225/contributors\">",
"     Sihoun Hahn, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/49/19225/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/49/19225/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?18/49/19225/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 26, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The urea cycle is the metabolic pathway that transforms nitrogen to urea for excretion from the body (",
"    <a class=\"graphic graphic_figure graphicRef60652 \" href=\"UTD.htm?2/49/2832\">",
"     figure 1",
"    </a>",
"    ). Deficiency of an enzyme in the pathway causes a urea cycle disorder (UCD). The urea cycle disorders are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Carbamoyl phosphate synthetase I (CPSI) deficiency (MIM #237300)",
"     </li>",
"     <li>",
"      Ornithine transcarbamylase (OTC) deficiency (MIM #311250)",
"     </li>",
"     <li>",
"      Argininosuccinate synthetase (ASS) deficiency (also known as classic citrullinemia or type I citrullinemia, CTLN1, MIM #215700)",
"     </li>",
"     <li>",
"      Argininosuccinate lyase (ASL) deficiency (also known as argininosuccinic aciduria, MIM #207900)",
"     </li>",
"     <li>",
"      N-acetyl glutamate synthetase (NAGS) deficiency (MIM #237310)",
"     </li>",
"     <li>",
"      Arginase deficiency (also known as argininemia, MIM #207800)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    UCDs, except for arginase deficiency, result in hyperammonemia and life-threatening illnesses. Survivors of the metabolic decompensation frequently have severe neurologic injury that correlates with the cumulative duration of hyperammonemia. Prompt recognition and treatment are needed to improve outcome.",
"   </p>",
"   <p>",
"    The management of urea cycle disorders is discussed here. The clinical features and diagnosis of urea cycle disorders are discussed separately. A general overview of inborn errors of metabolism is also presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/49/20248?source=see_link\">",
"     \"Urea cycle disorders: Clinical features and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/26/27047?source=see_link\">",
"     \"Inborn errors of metabolism: Classification\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/58/24489?source=see_link\">",
"     \"Inborn errors of metabolism: Epidemiology, pathogenesis, and clinical features\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/0/10250?source=see_link\">",
"     \"Inborn errors of metabolism: Metabolic emergencies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INITIAL MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neurologic abnormalities and impaired cognitive function are significantly correlated with the duration of hyperammonemia and encephalopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Thus, treatment should be initiated as soon as a UCD is suspected and should proceed concurrently with the diagnostic evaluation [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/3-6\">",
"     3-6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/49/20248?source=see_link&amp;anchor=H2417101#H2417101\">",
"     \"Urea cycle disorders: Clinical features and diagnosis\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The initial approach to treatment consists of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Rehydrate and maintain good urine output without overhydration",
"     </li>",
"     <li>",
"      Remove nitrogen (ammonia) from the body using medications",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      hemodialysis",
"     </li>",
"     <li>",
"      Stop protein intake and minimize catabolism",
"     </li>",
"     <li>",
"      Stimulate anabolism and uptake of nitrogen precursors by muscle",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Respiratory status should be closely monitored because clinical condition can deteriorate rapidly. Patients with respiratory failure should receive assisted ventilation because increased work of breathing results in higher caloric demands, leading to increased catabolism and nitrogen accumulation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/61/7130?source=see_link\">",
"     \"Emergent evaluation of acute respiratory compromise in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/39/4729?source=see_link\">",
"     \"Mechanical ventilation in neonates\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/1/13336?source=see_link\">",
"     \"Overview of mechanical ventilation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/48/43784?source=see_link\">",
"     \"Modes of mechanical ventilation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most newborns with clinical features of a UCD are treated with broad spectrum antibiotics because sepsis is suspected. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/16/6410?source=see_link\">",
"     \"Clinical features and diagnosis of sepsis in term and late preterm infants\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Glucocorticoids increase protein catabolism and should not routinely be used.",
"   </p>",
"   <p>",
"    Valproic acid decreases urea cycle function and increases serum ammonia levels and should",
"    <strong>",
"     not",
"    </strong>",
"    be used to treat seizures. Seizures may be treated with other antiepileptic drugs, although correcting the underlying metabolic abnormality is more likely to affect seizure control. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/32/37386?source=see_link\">",
"     \"Overview of the treatment of seizures and epileptic syndromes in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?42/60/43975?source=see_link\">",
"     Mannitol",
"    </a>",
"    is ineffective in treating cerebral edema caused by hyperammonemia due to UCDs. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/37/44633?source=see_link\">",
"     \"Elevated intracranial pressure in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hyperammonemia may be induced by drugs that inhibit urea synthesis (eg, valproic acid) and these drugs should be avoided in patients with UCDs [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/7\">",
"     7",
"    </a>",
"    ]. Drugs that may have direct hepatotoxicity also should be used cautiously.",
"   </p>",
"   <p>",
"    Symptomatic newborns with hyperammonemia should be cared for in a center with established experience in the diagnosis and treatment of metabolic disorders, including hemodialysis. Optimally, care should be directed by a biochemical geneticist experienced in the management of inborn errors of metabolism.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     VOLUME REPLETION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptomatic patients typically are volume depleted because of a history of poor feeding",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    recurrent vomiting. Reduced tissue perfusion can further increase protein catabolism and nitrogen load and lead to increased ammonia concentrations. In addition, pharmacologic treatment of UCDs requires good renal function. Thus, repletion of intravascular fluid is a priority. However, the fluid infusion rate should be adjusted carefully, because overhydration may worsen the intracellular cerebral edema caused by hyperammonemia.",
"   </p>",
"   <p>",
"    Intravenous access, preferably via a central catheter, should be established for blood sampling and for the administration of fluids and medications. Intravenous fluids should consist of 10 percent dextrose in water, although significant and prolonged hyperglycemia should be avoided. Saline infusion should be minimized because of the high saline content of nitrogen scavenging medications. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Pharmacologic therapy'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     AMMONIA REMOVAL",
"    </span>",
"    &nbsp;&mdash;&nbsp;Excessive ammonia is removed by hemodialysis and medications. Hemodialysis is the quickest and most efficient method and should be used if ammonia is rapidly increasing, the acute hyperammonemia is resistant to initial drug therapy,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the ammonia is persistently above the range of 350 to 400",
"    <span class=\"nowrap\">",
"     micromol/L",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/8\">",
"     8",
"    </a>",
"    ]. Newborns with acute (less than 24 to 48 hours' duration) and severe hyperammonemia should be cared for in a center capable of performing hemodialysis. Exchange transfusion does not effectively remove ammonia and should not be used [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/9\">",
"     9",
"    </a>",
"    ]. Intravenous fluid administration, rather than hemodialysis, is often sufficient therapy in patients with arginase deficiency who present with milder hyperammonemia [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Hemodialysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hemodialysis should be started as soon as possible after hospital admission of a patient with severe hyperammonemia. Continuous arteriovenous or venovenous hemodialysis (CAVHD or CVVHD) with flow rates &gt;40 to 60",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    is optimal. Some centers use extracorporeal membrane oxygenation (ECMO) with hemodialysis. This technique provides very high flow rates (170 to 200",
"    <span class=\"nowrap\">",
"     mL/min)",
"    </span>",
"    and rapidly reduces ammonia levels, but with greater morbidity associated with surgical vascular access [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If these procedures are not available, continuous arteriovenous or venovenous hemofiltration",
"    <span class=\"nowrap\">",
"     (CAVH/CVVH)",
"    </span>",
"    may be used. This method is less desirable as an initial treatment, although it can be used effectively between hemodialysis treatments to continue removing ammonia (also known as detoxification). Peritoneal dialysis is the least acceptable method because clearance of ammonia is very slow and detoxification may take several days; it should be used only if no other option is available [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/12\">",
"     12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/39/38516?source=see_link&amp;anchor=H2#H2\">",
"     \"Continuous renal replacement therapies: Overview\", section on 'Terminology'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/58/1962?source=see_link\">",
"     \"Adequacy of peritoneal dialysis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hemodialysis is stopped when the ammonia concentration has dropped below 200",
"    <span class=\"nowrap\">",
"     micromol/L,",
"    </span>",
"    because it appears to have little effect below this level. However, plasma ammonia may increase again (rebound) because of the delay in the effect of nitrogen scavenging medications and the ongoing catabolism that continues to produce waste nitrogen. Reversal of the catabolic process typically takes 24 to 48 hours; it may take longer if infection is present. During this period, hemofiltration can be used to clear the newly produced nitrogen. Dialysis catheters should be kept in place until ammonia levels have been stable for at least 24 hours.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Pharmacologic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pharmacologic therapy of hyperammonemia consists of administration of a combination preparation of sodium phenylacetate and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?32/6/32866?source=see_link\">",
"     sodium benzoate",
"    </a>",
"    . These drugs scavenge ammonia by creating an alternate pathway to excrete nitrogen precursors [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/13\">",
"     13",
"    </a>",
"    ]. Phenylacetate combines with glutamine to form phenylacetylglutamine and benzoate combines with glycine to form hippurate [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. These conjugation products are water soluble and are excreted in the urine. Thus, adequate renal function is essential [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/16\">",
"     16",
"    </a>",
"    ]. Disposal of glutamine and glycine reduces the total nitrogen pool. Pharmacokinetics for the biochemical conversions may vary from patient to patient. Signs of toxicity should be monitored during treatment. Drug levels can be obtained in specialized labs, but such testing is usually not accessible in the emergent treatment scenario.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Sodium phenylacetate and sodium benzoate",
"    </span>",
"    &nbsp;&mdash;&nbsp;A combined preparation of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?2/32/2565?source=see_link\">",
"     sodium phenylacetate-sodium benzoate",
"    </a>",
"    (Ammonul) was approved by the United States Food and Drug Administration in February 2005 for parenteral delivery. For patients who weigh &le;20 kg, we use a loading dose of 500",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    (250",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    of each drug) in a volume of 25 to 35",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    of 10 percent dextrose solution infused over 90 minutes. For patients who weigh &gt;20 kg, dosing is based upon body surface area; the loading dose is 11",
"    <span class=\"nowrap\">",
"     g/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    (ie, 5.5",
"    <span class=\"nowrap\">",
"     g/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    of each drug). The loading dose may be repeated in rare case that a patient does not respond to dialysis; drug levels could be monitored in this circumstance to avoid toxicity, including death [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Maintenance infusion of Ammonul (500",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per 24 hours for patients &lt;20 kg, 11",
"    <span class=\"nowrap\">",
"     g/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    per 24 hours as a continuous infusion for patients &gt;20 kg) is started when the loading dose is completed. Maintenance infusion of Ammonul is continued until oral",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?11/20/11588?source=see_link\">",
"     sodium phenylbutyrate",
"    </a>",
"    can be tolerated (see",
"    <a class=\"local\" href=\"#H15\">",
"     'Management of infants after initial stabilization'",
"    </a>",
"    below). Additional intravenous fluid, 10 percent dextrose supplemented with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?5/18/5412?source=see_link\">",
"     potassium acetate",
"    </a>",
"    (2 to 4",
"    <span class=\"nowrap\">",
"     meq/100",
"    </span>",
"    mL), should be given to provide a total of 1 to 1.5 times daily maintenance fluid requirements. The potassium will counteract the hypokalemic effects of the large sodium load (assuming normal urine output), while the acetate base will counteract the potential acidosis due to the large chloride load.",
"   </p>",
"   <p>",
"    The effect of treatment with intravenous",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?2/32/2565?source=see_link\">",
"     sodium phenylacetate-sodium benzoate",
"    </a>",
"    on survival in patients with UCDs was evaluated in a 25-year (1980 to 2005) nonrandomized, uncontrolled, open-label study at 118 hospitals [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/18\">",
"     18",
"    </a>",
"    ]. The study included 299 patients in whom there were 1181 episodes of hyperammonemia. Dialysis was used in addition to sodium phenylacetate-",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?32/6/32866?source=see_link\">",
"     sodium benzoate",
"    </a>",
"    for 60 percent of episodes of hyperammonemia in patients &lt;30 days of age and for 7 percent of episodes of hyperammonemia in patients &gt;30 days of age. Neurologic outcome was not evaluated.",
"   </p>",
"   <p>",
"    Overall survival was 84 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/18\">",
"     18",
"    </a>",
"    ]. Survival following episodes of hyperammonemia was 96 percent (73 percent in patients &lt;30 days of age, 98 percent in patients &gt;30 days of age, and 81 percent in patients who were comatose at the time of admission). By way of comparison, survival in 217 patients from a single institution who did not receive alternative pathway therapy was 16 percent for those with neonatal onset UCD and 72 percent for those with late-onset UCD [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Adverse effects of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?2/32/2565?source=see_link\">",
"     sodium phenylacetate-sodium benzoate",
"    </a>",
"    therapy occurred in approximately one-half of patients; most of these were metabolic (eg, hypokalemia, hyperchloremia, acidosis), neurologic (eg, seizures), or respiratory (eg, respiratory distress or failure) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/18\">",
"     18",
"    </a>",
"    ]. Among the 49 patients who died, 13 received higher than recommended doses of sodium phenylacetate and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?32/6/32866?source=see_link\">",
"     sodium benzoate",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Arginine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Enzyme deficiencies in the urea cycle (with the exception of arginase deficiency) prevent the formation of arginine, thus rendering it an essential amino acid [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/20\">",
"     20",
"    </a>",
"    ]. Arginine deficiency results in a catabolic state that stimulates further mobilization of nitrogen from protein breakdown. In OTC, ASS, and ASL deficiency, arginine also is needed to generate urea cycle intermediates, including ornithine, citrulline, and argininosuccinic acid. When arginine is provided, these water-soluble compounds can be formed and excreted, resulting in additional removal of ammonia [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/21-23\">",
"     21-23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We administer intravenous arginine hydrochloride as part of the initial management along with dialysis and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?2/32/2565?source=see_link\">",
"     sodium phenylacetate-sodium benzoate",
"    </a>",
"    . In the absence of a diagnosis of the specific form of UCD, and for patients &le;20 kg, the loading dose is 200",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    dissolved in 25 to 35",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    of 10 percent dextrose solution infused over 90 minutes. For patients &gt;20 kg, the loading dose is 4",
"    <span class=\"nowrap\">",
"     g/m",
"     <sup>",
"      2",
"     </sup>",
"     .",
"    </span>",
"   </p>",
"   <p>",
"    The maintenance dose is started after the loading dose. In CPSI or OTC deficiency, or if the specific UCD is not yet identified, the maintenance dose is 200",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per 24 hours for patients &le;20 kg and 4",
"    <span class=\"nowrap\">",
"     g/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    per 24 hours for patients &gt;20 kg. For ASS and ASL deficiency, the maintenance dose is 600",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per 24 hours for patients &le;20 kg and 12",
"    <span class=\"nowrap\">",
"     g/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    per 24 hours for patients &gt;20 kg intravenous. This higher dose of arginine increases the generation of citrulline (in ASS deficiency) and argininosuccinic acid (in ASL deficiency), which enhances nitrogen excretion. Blood pressure should be monitored, since high doses of intravenous arginine can decrease blood pressure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Citrulline",
"    </span>",
"    &nbsp;&mdash;&nbsp;In OTC or CPS deficiency, small oral doses of citrulline (150 to 200",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per 24 hours for patients &le;20 kg and 3 to 4",
"    <span class=\"nowrap\">",
"     g/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    per 24 hours for patients &gt;20 kg) also are provided, because of the theoretical advantage of incorporating aspartate nitrogen for clearance as urea in disorders upstream of ASS. Citrulline should not be given if the diagnosis is unknown, because citrulline levels are elevated in ASS and ASL deficiencies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Carglumic acid",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/49/38675?source=see_link\">",
"     Carglumic acid",
"    </a>",
"    (Carbaglu), which was previously available outside the United States, was approved by the US Food and Drug Administration in March 2010, for treatment of hyperammonemia due to N-acetylglutamate synthase (NAGS) deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/24,25\">",
"     24,25",
"    </a>",
"    ]. Carglumic acid is able to activate the first enzyme of the urea cycle (CPSI), leading to rapid reduction of plasma ammonia to normal levels. It is used for both acute and chronic hyperammonemia due to NAGS deficiency.",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?2/32/2565?source=see_link\">",
"     Sodium phenylacetate-sodium benzoate",
"    </a>",
"    (Ammonul) is used in addition to carglumic acid if the hyperammonemia is severe, otherwise carglumic acid can be used alone. The initial dose for acute hyperammonemia ranges from 100 to 250",
"    <span class=\"nowrap\">",
"     mg/kg/day",
"    </span>",
"    orally (prepared as a liquid and divided into two to four doses that are given immediately before meals). The dose is adjusted according to the patient's symptoms and plasma ammonia level. The dose for maintenance treatment of chronic hyperammonemia is typically &lt;100",
"    <span class=\"nowrap\">",
"     mg/kg/day.",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Laboratory monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;Electrolytes",
"    should be monitored daily during loading and maintenance infusions of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?2/32/2565?source=see_link\">",
"     sodium phenylacetate-sodium benzoate",
"    </a>",
"    because these medications contain high concentrations of sodium and chloride. Sodium phenylacetate administration may cause potassium depletion.",
"   </p>",
"   <p>",
"    Ammonia concentration is measured hourly during dialysis. After dialysis is completed and ammonia levels have stabilized below 200",
"    <span class=\"nowrap\">",
"     micromol/L",
"    </span>",
"    for at least 24 hours, the frequency of measurements can be reduced to every four hours. Testing can be reduced further to every 12 hours after a stable oral drug regimen is established and then daily until the patient is clinically ready for discharge from the hospital.",
"   </p>",
"   <p>",
"    Serum amino acids can be measured daily, if immediate testing is available, to help assess the efficacy of glutamine removal and to determine if replacement of arginine",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    citrulline is sufficient. Neurologic morbidity is directly correlated with the duration of hyperammonemia. Hence, normalization of blood ammonia levels should be the management priority.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     PROTEIN RESTRICTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Catabolic stress should be avoided and protein intake should be restricted to minimize the nitrogen load from protein breakdown or feeding [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/26\">",
"     26",
"    </a>",
"    ]. On the other hand, excessive and prolonged restriction of protein intake will stimulate peripheral mobilization of nitrogen.",
"   </p>",
"   <p>",
"    In acute hyperammonemia with encephalopathy, oral feedings are discontinued. Calories are provided by intravenous administration of lipids and glucose, and protein intake is stopped. Protein should not be completely restricted longer than the first 24 to 48 hours after treatment is initiated to avoid protein catabolism resulting in increased circulating nitrogen. If enteral intake of amino acids is not possible because of neurologic compromise, essential amino acids should be administered parenterally.",
"   </p>",
"   <p>",
"    The recommended daily protein intake varies with age and ranges from 2.0 to 2.5",
"    <span class=\"nowrap\">",
"     gm/kg",
"    </span>",
"    per day at birth to less than 0.6 to 0.8",
"    <span class=\"nowrap\">",
"     gm/kg",
"    </span>",
"    per day in adults. Children with UCDs typically require even less than the recommended daily intake of protein for normal growth. Patients with partial deficiency of a urea cycle enzyme may tolerate greater protein intake. The daily intake of protein and amino acids is adjusted according to the patient's age, growth rate, monitoring laboratories (ie, essential amino acid levels in the blood, prealbumin, albumin, and hemoglobin), and clinical course.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;During the transition to food protein, we measure serum levels of essential amino acids (eg, branched chain amino acids, phenylalanine, lysine), which reflect adaptation to the protein intake during the previous 48 hours. The target goal is the low normal range for these essential amino acids. Samples are obtained three to four hours after feeding and repeated every two to three days.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     MANAGEMENT OF INFANTS AFTER INITIAL STABILIZATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;In newborns who have stabilized, we begin by providing approximately 1.5 to 1.75",
"    <span class=\"nowrap\">",
"     gm/kg",
"    </span>",
"    per day of protein as an intravenous amino acid solution. We monitor ammonia levels at least daily and plasma amino acid levels at least every two to three days. If this rate of protein infusion is tolerated, we discontinue the intravenous infusion of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?2/32/2565?source=see_link\">",
"     sodium phenylacetate-sodium benzoate",
"    </a>",
"    and administer oral",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?11/20/11588?source=see_link\">",
"     sodium phenylbutyrate",
"    </a>",
"    (Buphenyl, 400 to 600",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per 24 hours for patients &le;20 kg and 9 to 13",
"    <span class=\"nowrap\">",
"     g/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    per 24 hours for patients &gt;20 kg). Sodium phenylbutyrate is converted to phenylacetate, which promotes urinary clearance of nitrogenous waste. Citrulline (170",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day orally) is given in OTC and CPSI deficiencies, and arginine base (500",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day orally),",
"    <strong>",
"     not",
"    </strong>",
"    the arginine hydrochloride solution used in intravenous therapy, is given in ASS and ASL deficiencies. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Pharmacologic therapy'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/8/2177?source=see_link\">",
"     glycerol phenylbutyrate",
"    </a>",
"    (Ravicti, 4.5 to 11.2",
"    <span class=\"nowrap\">",
"     mL/m",
"     <sup>",
"      2",
"     </sup>",
"     /day",
"    </span>",
"    divided in three equal doses) is an alternative to oral",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?11/20/11588?source=see_link\">",
"     sodium phenylbutyrate",
"    </a>",
"    that is approved for patients greater than two years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. Glycerol phenylbutyrate is a pre-prodrug of phenylacetate. It requires pancreatic lipase conversion into phenylbutyrate, which is then oxidized into phenylacetate. Thus, it acts as a slow release form of sodium phenylbutyrate, achieving more stable control of ammonia levels over a 24 hour period. In addition, it may offer advantages with regards to tolerability and palatability, since it is a colorless and tasteless oil with no sodium content. However, its use is contraindicated in infants under two months of age due to immature pancreatic exocrine function that could lead to insufficient drug metabolism. In a randomized crossover trial of 45 adults with UCD, glycerol phenylbutyrate was noninferior to sodium phenylbutyrate in controlling ammonia levels over 24 hours. In an uncontrolled 12 month extension study, patients showed improved measures of executive functioning compared with baseline on enrollment. A direct conversion of dosing can be calculated for patients already on sodium phenylbutyrate: Total daily dose glycerol phenylbutyrate (mL) = 0.8 X total daily dose sodium phenylbutyrate (grams). Dosing can be guided by fasting ammonia levels (with a target less than half the upper limit of normal), serum phenylacetate levels, and urinary phenylacetylglutamine levels [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Enteral feeding is initiated as soon as possible. A nasogastric tube may be needed to ensure appropriate intake. Infants are fed a protein-free formula, such as Mead Johnson 80056 or Ross Formula ProPhree in conjunction with amino acid mixtures and cow milk-based formulas. One-half of the daily protein requirement is usually given as amino acid mixture and one-half as cow milk protein because the nitrogen load in free amino acid solutions is less than that of complex proteins. A dietitian experienced in dietary therapy of inborn errors of metabolism should manage the diet. The daily fluid intake required to maintain a good urine output should also be calculated.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?11/20/11588?source=see_link\">",
"     Sodium phenylbutyrate",
"    </a>",
"    , sodium phenylacetate, and probably also",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/8/2177?source=see_link\">",
"     glycerol phenylbutyrate",
"    </a>",
"    , can selectively depress branched chain amino acids (leucine, valine, and isoleucine) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/30\">",
"     30",
"    </a>",
"    ]. Branched chain amino acid supplementation may be warranted in patients who have low concentrations of leucine, valine, and isoleucine and other signs of protein insufficiency (eg, low prealbumin and albumin), especially if they have normal concentrations of other essential amino acids. Chronic administration of sodium phenylbutyrate is associated with significant gastrointestinal side effects (eg, gastritis); therefore proton pump inhibitors, such as",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?24/23/24952?source=see_link\">",
"     omeprazole",
"    </a>",
"    should be considered. Significant gastrointestinal side effects are not expected with glycerol phenylbutyrate due to differences in drug metabolism. Monitoring of chronic therapy includes plasma amino acids, measures of liver function, and nutritional markers (eg, prealbumin, albumin, plasma amino acids, complete blood count). The frequency of monitoring depends upon the age of the patient and can range from every one to two months in a growing infant to once per year in an adult.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     DISCHARGE PLANNING",
"    </span>",
"    &nbsp;&mdash;&nbsp;A stable feeding route should be established before the patient is discharged from the hospital. A gastrostomy tube usually is the most reliable method to control protein and caloric intake routinely and allows administration of additional fluid and medication during viral illnesses.",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?11/20/11588?source=see_link\">",
"     Sodium phenylbutyrate",
"    </a>",
"    is very bitter, and feeding avoidance may develop when it is given orally. Thus, administration through the gastrostomy tube is preferable. Fundoplication is usually not indicated and it may disguise clinical signs of hyperammonemia (ie, vomiting).",
"   </p>",
"   <p>",
"    Adequate time should be available for parents to become familiar with the medications, formulas, and dietary supplements. Parents must be taught to recognize the signs of early hyperammonemia, including irritability and vomiting. They should know the factors that may trigger a metabolic crisis, such as infection or fever, and understand the importance of preventive measures. There is no association between hyperammonemic episodes and immunizations in children with UCDs [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/31\">",
"     31",
"    </a>",
"    ], nor is there an associated increased risk of serious adverse events due to immunizations in children with inborn errors of metabolism [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/32\">",
"     32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/56/39818?source=see_link\">",
"     \"Standard immunizations for children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20711053\">",
"    <span class=\"h1\">",
"     LONG-TERM MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;For chronic management, we assess the adequacy of protein intake over the course of weeks to months by measuring serum concentrations of total protein, albumin, and prealbumin, in addition to serial measurements of growth.",
"   </p>",
"   <p>",
"    For periods of increased stress, such as prior to parturition or surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/33,34\">",
"     33,34",
"    </a>",
"    ], maintenance of hydration is indicated. For more extensive procedures or when oral intake of medications is limited, intravenous infusion of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?2/32/2565?source=see_link\">",
"     sodium phenylacetate-sodium benzoate",
"    </a>",
"    and arginine should be instituted until oral diet and medication is tolerated. Ammonia levels should be monitored during these periods.",
"   </p>",
"   <p>",
"    Protein tolerance in affected children usually increases with age. Thus, the greatest risk of hyperammonemia during the first year is due to the protein catabolism associated with viral illnesses. Efforts should be made to avoid infectious exposures, especially during the first year. Prophylaxis to respiratory syncytial virus should be considered. Parents should notify the metabolic specialist immediately if the child becomes ill or shows early signs of hyperammonemia. Protein intake can be adjusted during acute illnesses in conjunction with a metabolic dietician. The management of subsequent episodes of hyperammonemia is the same as the management for the initial episode.",
"   </p>",
"   <p>",
"    In specific disorders, unique pathophysiologic mechanisms may suggest adjunctive treatments. As an example, some patients with argininosuccinic aciduria have evidence of nitric oxide (NO) depletion and show signs of hypertension. This hypertension may be responsive to NO sources such as nitrite. In one case study, nitrite supplementation reversed chronic long standing hypertension that was unresponsive to other standard forms of therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/35\">",
"     35",
"    </a>",
"    ]. However, randomized trials that confirm efficacy are necessary before routine supplementation can be recommended. Intake of nitrite-rich foods is an acceptable conservative recommendation for the present.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6407689\">",
"    <span class=\"h1\">",
"     LIVER TRANSPLANTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some patients with UCD may be candidates for liver transplantation, because of the high risk of mortality and neurologic morbidity associated with UCDs [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/36-39\">",
"     36-39",
"    </a>",
"    ]. The indications for liver transplantation are relative. A careful analysis of the risks and benefits for individual patients should be performed by a multidisciplinary team of clinical biochemical geneticists, transplant surgeons, hepatologists, developmental pediatricians, psychologists, and social workers in conjunction with the family [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]. In the United States, liver transplantation is considered for newborns with CPSI or OTC deficiency, in patients who have not responded to medical therapy, and in ASL deficiency associated with cirrhosis. However, patients with any form of UCD may be candidates for liver transplantation if medical therapy has failed to prevent recurrent hyperammonemia.",
"   </p>",
"   <p>",
"    A review of 51 cases of liver transplantation for UCD (38 previously published reports and a series of 13 patients from one institution) revealed the following [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/42\">",
"     42",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Indications for liver transplantation included OTC deficiency (22 patients), type II ASS deficiency (type II citrullinemia, 20 patients), type I ASS deficiency (type I citrullinemia, four patients), arginase deficiency (one patient).",
"     </li>",
"     <li>",
"      The median age of onset of UCD was 31.5 months (range: 0 to 62 years) and the median time from onset of UCD to liver transplantation was nine months (range: 0.5 to 202 months).",
"     </li>",
"     <li>",
"      The overall cumulative patient survival was 91 percent at 5 and 10 years. There were two hospital mortalities, two deaths from complications of liver transplantation or remaining neurologic impairment, two deaths unrelated to liver transplantation or UCD, and one death from biliary complications related to graft failure.",
"     </li>",
"     <li>",
"      The overall cumulative graft survival was 89 percent at 5 and 10 years. There were three cases of graft failure related to biliary complications (one died, one required a second liver transplantation, and one was on a waiting list for repeat liver transplantation).",
"     </li>",
"     <li>",
"      Hyperammonemia and the need for dietary restrictions and alternative pathway medications were completely eradicated by liver transplantation in all surviving patients. Neurologic complications remained in 7 of the 47 patients in whom neurologic status was evaluated (six of these received their transplantation in early infancy). Neurologic impairments also were more likely to remain in patients who received deceased donor transplants than in those who received living donor transplants (6 of 21 versus 1 of 26).",
"     </li>",
"     <li>",
"      Among the 26 living donors 16 were known to be heterozygous for UCD, eight were not heterozygous, and the status of two sibling donors was not known (they had a 50 percent chance of being heterozygous). There were no descriptions of mortality or morbidity related to the use of heterozygous donors. None of the donors showed consistent signs of hyperammonemia in the early postoperative period or later.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In another study, early liver transplantation in patients who presented with acute hyperammonemia of limited duration (&lt;24 hours on average) had improved developmental outcome compared to historical trends [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Orthotopic liver transplantation has a higher rate of complications when performed in infancy, primarily due to the size of the graft. However, delaying transplantation can lead to irreversible neurologic complications. Thus, alternative options are under investigation, including liver cell and stem cell transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/39\">",
"     39",
"    </a>",
"    ]. Liver cell transplantation is much less invasive and has been performed successfully in several newborns and older children. However, the long term stability of the transplant is uncertain; therefore the majority of the children who have survived liver cell transplantation have gone on to have orthotopic liver transplantation. The feasibility of liver stem cell transplantation is under investigation in animal models.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31503142\">",
"    <span class=\"h2\">",
"     Hepatocyte cell transplantation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hepatocyte cell transplantation studies have been initiated, although their efficacy remains to be demonstrated [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H764183\">",
"    <span class=\"h1\">",
"     GENE THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gene therapy was performed for OTC deficiency in 19 patients in a phase I trial [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/44-46\">",
"     44-46",
"    </a>",
"    ]. This trial was halted when the 19",
"    <sup>",
"     th",
"    </sup>",
"    patient died from a severe innate immune response to the vector [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/47-49\">",
"     47-49",
"    </a>",
"    ]. Significant metabolic correction did not occur in the 18 surviving subjects [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/46\">",
"     46",
"    </a>",
"    ]. No further human trials have been performed, but studies in mouse models of UCDs continue.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mortality and morbidity are still high in UCDs [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/1,50,51\">",
"     1,50,51",
"    </a>",
"    ], although survival rates have improved due to earlier diagnosis and improved treatments. In one report from Japan of 216 patients with UCDs treated from 1978 to 1995, 92 presented as newborns and the remainder had later onset [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/50\">",
"     50",
"    </a>",
"    ]. The five-year survival was 22 and 41 percent for the neonatal and late-onset UCDs, respectively. In a subsequent report from Japan of 177 patients treated from 1999 to 2009, 77 cases were neonatal-onset and 91 cases were late-onset [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/52\">",
"     52",
"    </a>",
"    ]. The five-year survival was 83 and 90 percent for early and late-onset, respectively.",
"   </p>",
"   <p>",
"    Patients often grow poorly and have neurodevelopmental problems [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/53\">",
"     53",
"    </a>",
"    ]. In the earlier Japanese study, 90 percent of the neonatal survivors and 28 percent of late-onset survivors had moderate to severe neurodevelopmental deficits [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/50\">",
"     50",
"    </a>",
"    ]. Outcome was associated with the peak blood ammonia concentration during the initial presentation. Severe damage was not seen if the ammonia concentration was &lt;180",
"    <span class=\"nowrap\">",
"     micromol/L,",
"    </span>",
"    whereas patients with levels &gt;350",
"    <span class=\"nowrap\">",
"     mmol/L",
"    </span>",
"    had severe deficits or died. In the second Japanese study, a peak initial ammonia concentration &gt;360",
"    <span class=\"nowrap\">",
"     micromol/L",
"    </span>",
"    was also a marker of poor prognosis, although 18 patients with levels above this cutoff at presentation had normal neurodevelopment [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In another study, long term neurologic morbidity was related to the duration of hyperammonemia and not to peak ammonia levels [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/2\">",
"     2",
"    </a>",
"    ]. In our experience, the outcome is better in newborns when the duration of hyperammonemia is less than 24 hours.",
"   </p>",
"   <p>",
"    Specific chronic complications include developmental delay, intellectual disability (mental retardation), learning problems, speech disorder, attention deficit hyperactivity disorder, cerebral palsy, and seizure disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/54\">",
"     54",
"    </a>",
"    ]. Some patients have hepatomegaly that may be associated with abnormal liver function tests, although the mechanism is unknown. Accumulated longitudinal data suggest that liver dysfunction is a common complication of UCDs. The liver dysfunction is not usually clinically significant, although it may be acutely exacerbated during intercurrent illness or metabolic decompensation.",
"   </p>",
"   <p>",
"    The natural history of these disorders continues to be elucidated. Some long term morbidity may be unrelated to hyperammonemia, and may instead reflect the integration of UC intermediates within intermediary metabolism. As an example, synthesis of nitric oxide (NO) is dependent upon arginine. Thus, dysregulation of NO function is possible in some UCDs in which arginine is depleted, such as argininosuccinic aciduria (ASA) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/55,56\">",
"     55,56",
"    </a>",
"    ]. Liver dysfunction can be a significant chronic complication of ASA due to deficiency of argininosuccinate lyase (ASL) that leads to depletion of arginine. In the same vein, neurologic morbidity does not appear to correlate with the frequency of hyperammonemia in patients with ASA [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/57\">",
"     57",
"    </a>",
"    ] and essential hypertension may also be associated with deficient NO production [",
"    <a class=\"abstract\" href=\"UTD.htm?18/49/19225/abstract/55\">",
"     55",
"    </a>",
"    ]. These emerging correlations are just beginning to be understood.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The urea cycle is the metabolic pathway that transforms nitrogen to urea for excretion from the body (",
"      <a class=\"graphic graphic_figure graphicRef60652 \" href=\"UTD.htm?2/49/2832\">",
"       figure 1",
"      </a>",
"      ). Urea cycle disorders (UCDs) are caused by deficiency of an enzyme in the pathway: carbamoyl phosphate synthetase I (CPSI), ornithine transcarbamylase (OTC), argininosuccinate synthetase (ASS), argininosuccinate lyase (ASL), N-acetyl glutamate synthetase (NAGS), and arginase. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The initial approach to treatment of UCD consists of volume repletion, ammonia removal, protein restriction, and stimulation of anabolism. Respiratory status must be closely monitored. Drugs that increase protein catabolism (eg, glucocorticoids), inhibit urea synthesis (eg, valproic acid), or have direct hepatotoxicity should be avoided. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Initial management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Volume repletion is necessary to minimize protein catabolism and nitrogen load and to maintain renal function. Intravenous fluids should consist of 10 percent dextrose in water with electrolytes; saline infusion should be minimized (ammonia scavenging medications have a high content of sodium and chloride). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Volume repletion'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Excessive ammonia is removed by dialysis and medications. Hemodialysis is the quickest and most efficient method. We recommend use of hemodialysis if ammonia is rapidly increasing, the acute hyperammonemia is resistant to initial drug therapy,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      the ammonia is persistently above the range of 350 to 400",
"      <span class=\"nowrap\">",
"       micromol/L",
"      </span>",
"      (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Ammonia removal'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5\">",
"       'Hemodialysis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pharmacologic therapy for hyperammonemia consists of initial intravenous administration of a combination preparation of sodium phenylacetate and",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?32/6/32866?source=see_link\">",
"       sodium benzoate",
"      </a>",
"      (Ammonul) followed by maintenance with oral",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?11/20/11588?source=see_link\">",
"       sodium phenylbutyrate",
"      </a>",
"      (Buphenyl) or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/8/2177?source=see_link\">",
"       glycerol phenylbutyrate",
"      </a>",
"      (Ravicti). These drugs scavenge ammonia by creating an alternate pathway to excrete nitrogen precursors. Administration of arginine is also necessary for all urea cycle disorders except arginase deficiency (argininemia), because deficiencies of these enzymes prevent the formation of arginine, resulting in a catabolic state. Arginine also generates more urea cycle intermediates upstream of the block. The urinary excretion of these upstream intermediates further acts as a nitrogen disposal pathway. In addition, administration of citrulline may be helpful in OTC and CPSI deficiencies; citrulline should not be administered if the enzyme deficiency is not known because citrulline levels are elevated in ASS and ASL deficiencies. Finally,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/49/38675?source=see_link\">",
"       carglumic acid",
"      </a>",
"      , which can activate the first enzyme in the urea cycle (CPSI) downstream of NAGS, is effective in treating NAGS deficiency. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Pharmacologic therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Laboratory monitoring during initial treatment for UCD includes measurement of: electrolytes (during loading and maintenance infusions of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?2/32/2565?source=see_link\">",
"       sodium phenylacetate-sodium benzoate",
"      </a>",
"      ); ammonia concentration (hourly during hemodialysis; less frequently once a stable oral regimen has been established); and serum amino acids (daily). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Laboratory monitoring'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Protein intake is restricted to minimize nitrogen load from protein breakdown or feeding. The recommended daily protein intake varies with age, growth rate, and clinical course. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Protein restriction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A stable feeding route should be established before the patient is discharged from the hospital. A gastrostomy tube is the most reliable method to control protein and caloric intake and ensure administration of additional fluid and medication during illness. In addition, parents must be familiar with the medications, formulas, dietary supplements, signs of early hyperammonemia, and potential triggers of metabolic crisis. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Discharge planning'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Some patients with UCD may be candidates for liver transplantation, because of the high risk of mortality and neurologic morbidity associated with UCDs. We suggest liver transplantation for newborns with CPSI or OTC deficiency, in patients who have not responded to medical therapy, and in ASL deficiency associated with cirrhosis (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H6407689\">",
"       'Liver transplantation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Mortality and morbidity are high in UCDs. Patients often grow poorly and have neurodevelopmental problems. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Prognosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/1\">",
"      Maestri NE, Clissold D, Brusilow SW. Neonatal onset ornithine transcarbamylase deficiency: A retrospective analysis. J Pediatr 1999; 134:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/2\">",
"      Msall M, Batshaw ML, Suss R, et al. Neurologic outcome in children with inborn errors of urea synthesis. Outcome of urea-cycle enzymopathies. N Engl J Med 1984; 310:1500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/3\">",
"      H&auml;berle J. Clinical practice: the management of hyperammonemia. Eur J Pediatr 2011; 170:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/4\">",
"      Lilliu F. Treatment of organic acidurias and urea cycle disorders. J Matern Fetal Neonatal Med 2010; 23 Suppl 3:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/5\">",
"      Walker V. Ammonia toxicity and its prevention in inherited defects of the urea cycle. Diabetes Obes Metab 2009; 11:823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/6\">",
"      Enns GM. Nitrogen sparing therapy revisited 2009. Mol Genet Metab 2010; 100 Suppl 1:S65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/7\">",
"      Kamoun PP, Rabier D. Valproate-induced inhibition of urea synthesis. Lancet 1987; 1:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/8\">",
"      Schaefer F, Straube E, Oh J, et al. Dialysis in neonates with inborn errors of metabolism. Nephrol Dial Transplant 1999; 14:910.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/9\">",
"      Donn SM, Swartz RD, Thoene JG. Comparison of exchange transfusion, peritoneal dialysis, and hemodialysis for the treatment of hyperammonemia in an anuric newborn infant. J Pediatr 1979; 95:67.",
"     </a>",
"    </li>",
"    <li>",
"     GeneReviews: Arginase Deficiency. file://www.ncbi.nlm.nih.gov/books/NBK1159/ (Accessed on September 21, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/11\">",
"      Summar M, Pietsch J, Deshpande J, Schulman G. Effective hemodialysis and hemofiltration driven by an extracorporeal membrane oxygenation pump in infants with hyperammonemia. J Pediatr 1996; 128:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/12\">",
"      Wong KY, Wong SN, Lam SY, et al. Ammonia clearance by peritoneal dialysis and continuous arteriovenous hemodiafiltration. Pediatr Nephrol 1998; 12:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/13\">",
"      Summar M. Current strategies for the management of neonatal urea cycle disorders. J Pediatr 2001; 138:S30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/14\">",
"      Darmaun D, Welch S, Rini A, et al. Phenylbutyrate-induced glutamine depletion in humans: effect on leucine metabolism. Am J Physiol 1998; 274:E801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/15\">",
"      Green TP, Marchessault RP, Freese DK. Disposition of sodium benzoate in newborn infants with hyperammonemia. J Pediatr 1983; 102:785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/16\">",
"      Brusilow SW, Valle DL, Batshaw M. New pathways of nitrogen excretion in inborn errors of urea synthesis. Lancet 1979; 2:452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/17\">",
"      Praphanphoj V, Boyadjiev SA, Waber LJ, et al. Three cases of intravenous sodium benzoate and sodium phenylacetate toxicity occurring in the treatment of acute hyperammonaemia. J Inherit Metab Dis 2000; 23:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/18\">",
"      Enns GM, Berry SA, Berry GT, et al. Survival after treatment with phenylacetate and benzoate for urea-cycle disorders. N Engl J Med 2007; 356:2282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/19\">",
"      Nassogne MC, H&eacute;ron B, Touati G, et al. Urea cycle defects: management and outcome. J Inherit Metab Dis 2005; 28:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/20\">",
"      Kline JJ, Hug G, Schubert WK, Berry H. Arginine deficiency syndrome. Its occurrence in carbamyl phosphate synthetase deficiency. Am J Dis Child 1981; 135:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/21\">",
"      Brusilow SW, Batshaw ML. Arginine therapy of argininosuccinase deficiency. Lancet 1979; 1:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/22\">",
"      Batshaw ML, Brusilow S, Waber L, et al. Treatment of inborn errors of urea synthesis: activation of alternative pathways of waste nitrogen synthesis and excretion. N Engl J Med 1982; 306:1387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/23\">",
"      Lee B, Yu H, Jahoor F, et al. In vivo urea cycle flux distinguishes and correlates with phenotypic severity in disorders of the urea cycle. Proc Natl Acad Sci U S A 2000; 97:8021.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/24\">",
"      Thompson CA. Carglumic acid approved to treat genetic hyperammonemia. Am J Health Syst Pharm 2010; 67:690.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/25\">",
"      Daniotti M, la Marca G, Fiorini P, Filippi L. New developments in the treatment of hyperammonemia: emerging use of carglumic acid. Int J Gen Med 2011; 4:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/26\">",
"      Singh RH. Nutritional management of patients with urea cycle disorders. J Inherit Metab Dis 2007; 30:880.",
"     </a>",
"    </li>",
"    <li>",
"     FDA news release. FDA approves new drug for the chronic management of some urea cycle disorders. file://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm337639.htm (Accessed on February 19, 2013).",
"    </li>",
"    <li>",
"     Ravicti (glycerol phenylbutyrate) prescribing information. https://www.ravicti.com//files/RAVICTI_Prescribing_Information.pdf (Accessed on February 19, 2013).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/29\">",
"      Mokhtarani M, Diaz GA, Rhead W, et al. Urinary phenylacetylglutamine as dosing biomarker for patients with urea cycle disorders. Mol Genet Metab 2012; 107:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/30\">",
"      Scaglia F, Carter S, O'Brien WE, Lee B. Effect of alternative pathway therapy on branched chain amino acid metabolism in urea cycle disorder patients. Mol Genet Metab 2004; 81 Suppl 1:S79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/31\">",
"      Morgan TM, Schlegel C, Edwards KM, et al. Vaccines are not associated with metabolic events in children with urea cycle disorders. Pediatrics 2011; 127:e1147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/32\">",
"      Klein NP, Aukes L, Lee J, et al. Evaluation of immunization rates and safety among children with inborn errors of metabolism. Pediatrics 2011; 127:e1139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/33\">",
"      Mendez-Figueroa H, Lamance K, Sutton VR, et al. Management of ornithine transcarbamylase deficiency in pregnancy. Am J Perinatol 2010; 27:775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/34\">",
"      Dutoit AP, Flick RR, Sprung J, et al. Anesthetic implications of ornithine transcarbamylase deficiency. Paediatr Anaesth 2010; 20:666.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/35\">",
"      Nagamani SC, Campeau PM, Shchelochkov OA, et al. Nitric-oxide supplementation for treatment of long-term complications in argininosuccinic aciduria. Am J Hum Genet 2012; 90:836.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/36\">",
"      Saudubray JM, Touati G, Delonlay P, et al. Liver transplantation in urea cycle disorders. Eur J Pediatr 1999; 158 Suppl 2:S55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/37\">",
"      Whitington PF, Alonso EM, Boyle JT, et al. Liver transplantation for the treatment of urea cycle disorders. J Inherit Metab Dis 1998; 21 Suppl 1:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/38\">",
"      Moini M, Mistry P, Schilsky ML. Liver transplantation for inherited metabolic disorders of the liver. Curr Opin Organ Transplant 2010; 15:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/39\">",
"      Meyburg J, Hoffmann GF. Liver, liver cell and stem cell transplantation for the treatment of urea cycle defects. Mol Genet Metab 2010; 100 Suppl 1:S77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/40\">",
"      Sundaram SS, Alonso EM, Whitington PF. Liver transplantation in neonates. Liver Transpl 2003; 9:783.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/41\">",
"      McBride KL, Miller G, Carter S, et al. Developmental outcomes with early orthotopic liver transplantation for infants with neonatal-onset urea cycle defects and a female patient with late-onset ornithine transcarbamylase deficiency. Pediatrics 2004; 114:e523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/42\">",
"      Morioka D, Kasahara M, Takada Y, et al. Current role of liver transplantation for the treatment of urea cycle disorders: a review of the worldwide English literature and 13 cases at Kyoto University. Liver Transpl 2005; 11:1332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/43\">",
"      Meyburg J, Das AM, Hoerster F, et al. One liver for four children: first clinical series of liver cell transplantation for severe neonatal urea cycle defects. Transplantation 2009; 87:636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/44\">",
"      Batshaw ML, Robinson MB, Ye X, et al. Correction of ureagenesis after gene transfer in an animal model and after liver transplantation in humans with ornithine transcarbamylase deficiency. Pediatr Res 1999; 46:588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/45\">",
"      Batshaw ML, Wilson JM, Raper S, et al. Recombinant adenovirus gene transfer in adults with partial ornithine transcarbamylase deficiency (OTCD). Hum Gene Ther 1999; 10:2419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/46\">",
"      Raper SE, Yudkoff M, Chirmule N, et al. A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency. Hum Gene Ther 2002; 13:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/47\">",
"      Wilson JM. Lessons learned from the gene therapy trial for ornithine transcarbamylase deficiency. Mol Genet Metab 2009; 96:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/48\">",
"      Raper SE, Chirmule N, Lee FS, et al. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab 2003; 80:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/49\">",
"      Lehrman S. Virus treatment questioned after gene therapy death. Nature 1999; 401:517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/50\">",
"      Uchino T, Endo F, Matsuda I. Neurodevelopmental outcome of long-term therapy of urea cycle disorders in Japan. J Inherit Metab Dis 1998; 21 Suppl 1:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/51\">",
"      Maestri NE, Clissold DB, Brusilow SW. Long-term survival of patients with argininosuccinate synthetase deficiency. J Pediatr 1995; 127:929.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/52\">",
"      Kido J, Nakamura K, Mitsubuchi H, et al. Long-term outcome and intervention of urea cycle disorders in Japan. J Inherit Metab Dis 2012; 35:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/53\">",
"      Krivitzky L, Babikian T, Lee HS, et al. Intellectual, adaptive, and behavioral functioning in children with urea cycle disorders. Pediatr Res 2009; 66:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/54\">",
"      Berry GT, Steiner RD. Long-term management of patients with urea cycle disorders. J Pediatr 2001; 138:S56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/55\">",
"      Brunetti-Pierri N, Erez A, Shchelochkov O, et al. Systemic hypertension in two patients with ASL deficiency: a result of nitric oxide deficiency? Mol Genet Metab 2009; 98:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/56\">",
"      Nagasaka H, Tsukahara H, Yorifuji T, et al. Evaluation of endogenous nitric oxide synthesis in congenital urea cycle enzyme defects. Metabolism 2009; 58:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/49/19225/abstract/57\">",
"      Seminara J, Tuchman M, Krivitzky L, et al. Establishing a consortium for the study of rare diseases: The Urea Cycle Disorders Consortium. Mol Genet Metab 2010; 100 Suppl 1:S97.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2923 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-115.66.252.144-FC8D04C3D0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_49_19225=[""].join("\n");
var outline_f18_49_19225=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INITIAL MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      VOLUME REPLETION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      AMMONIA REMOVAL",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Hemodialysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Pharmacologic therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Sodium phenylacetate and sodium benzoate",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Arginine",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Citrulline",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Carglumic acid",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Laboratory monitoring",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      PROTEIN RESTRICTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Monitoring",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      MANAGEMENT OF INFANTS AFTER INITIAL STABILIZATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      DISCHARGE PLANNING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20711053\">",
"      LONG-TERM MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6407689\">",
"      LIVER TRANSPLANTATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31503142\">",
"      Hepatocyte cell transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H764183\">",
"      GENE THERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/2923\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/2923|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?2/49/2832\" title=\"figure 1\">",
"      Urea cycle",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/58/1962?source=related_link\">",
"      Adequacy of peritoneal dialysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/16/6410?source=related_link\">",
"      Clinical features and diagnosis of sepsis in term and late preterm infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/39/38516?source=related_link\">",
"      Continuous renal replacement therapies: Overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/37/44633?source=related_link\">",
"      Elevated intracranial pressure in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/61/7130?source=related_link\">",
"      Emergent evaluation of acute respiratory compromise in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/26/27047?source=related_link\">",
"      Inborn errors of metabolism: Classification",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/58/24489?source=related_link\">",
"      Inborn errors of metabolism: Epidemiology, pathogenesis, and clinical features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/0/10250?source=related_link\">",
"      Inborn errors of metabolism: Metabolic emergencies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/39/4729?source=related_link\">",
"      Mechanical ventilation in neonates",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/48/43784?source=related_link\">",
"      Modes of mechanical ventilation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/1/13336?source=related_link\">",
"      Overview of mechanical ventilation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/32/37386?source=related_link\">",
"      Overview of the treatment of seizures and epileptic syndromes in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/56/39818?source=related_link\">",
"      Standard immunizations for children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/49/20248?source=related_link\">",
"      Urea cycle disorders: Clinical features and diagnosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_49_19226="Acne closed comedones";
var content_f18_49_19226=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F62816%7EDERM%2F70809%7EPC%2F68412&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F62816%7EDERM%2F70809%7EPC%2F68412&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mild acne",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 322px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This 14-year-old girl has multiple closed comedones and scattered, small inflammatory papules and pustules on the forehead.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Douglas Hoffman, MD, Dermatlas; file://www.dermatlas.org.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Inflammatory acne",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Erythematous papules and pustules are present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Inflammatory and noninflammatory acne",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 266px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The face of this teenager shows open and closed comedones, papules, and pustules.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission: Goodheart, HP. Goodheart's Photoguide of Common Skin Disorders, 2nd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy;2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_49_19226=[""].join("\n");
var outline_f18_49_19226=null;
var title_f18_49_19227="Treatment of latent TB infection in pregnancy";
var content_f18_49_19227=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F73637&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F73637&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Treatment of latent tuberculosis in pregnancy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       &nbsp;",
"      </td>",
"      <td class=\"subtitle1\">",
"       Adults",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"6\">",
"       Isoniazid",
"      </td>",
"      <td>",
"       Preferred:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       300 mg PO daily for 9 months",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Alternate regimens:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       300 mg PO daily for 6 months",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       900 mg PO twice weekly* for 9 months",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       900 mg PO twice weekly* for 6 months",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Pyridoxine&bull;",
"      </td>",
"      <td>",
"       25-50 mg PO daily",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       Alternative to isoniazid:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Rifampin",
"      </td>",
"      <td>",
"       600 mg PO daily for 4 months",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Twice weekly regimens must be administered with directly observed therapy (DOT).",
"     <br>",
"      &bull; Pyridoxine should be administered to pregnant women as well as to infants of breastfeeding mothers receiving isoniazid.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_49_19227=[""].join("\n");
var outline_f18_49_19227=null;
var title_f18_49_19228="ACG first-line H pylori regimens";
var content_f18_49_19228=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F65237&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F65237&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    American College of Gastroenterology first-line",
"    <em>",
"     H. pylori",
"    </em>",
"    regimens (adult dosing, oral administration)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"2\" width=\"50%\">",
"     </colgroup>",
"     <tbody>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Patients who are",
"        <strong>",
"         not",
"        </strong>",
"        allergic to penicillin and have not previously received a macrolide",
"       </td>",
"       <td>",
"        Standard dose PPI* twice daily (or esomeprazole 40 mg once daily) plus clarithromycin 500 mg twice daily, and amoxicillin 1000 mg twice daily for 10-14 days",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Patients who are allergic to penicillin, and who have not previously received a macrolide or metronidazole or are unable to tolerate bismuth quadruple therapy",
"       </td>",
"       <td>",
"        Standard dose PPI twice daily, clarithromycin 500 mg twice daily, metronidazole 500 mg twice daily for 10-14 days",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Patients who are allergic to penicillin or failed one course (above) of",
"        <em>",
"         H. pylori",
"        </em>",
"        treatment",
"       </td>",
"       <td>",
"        <p>",
"         Bismuth subsalicylate 525 mg four times daily, metronidazole 250 mg four times daily, tetracycline 500 mg four times daily, standard dose PPI* twice daily for 10-14 days",
"         <sup>",
"          &Delta;",
"         </sup>",
"        </p>",
"        <p>",
"         <strong>",
"          OR",
"         </strong>",
"        </p>",
"        Bismuth subcitrate 420 mg four times daily, metronidazole 375 mg four times daily, tetracycline 375 mg four times daily",
"        <sup>",
"         &loz;",
"        </sup>",
"        , standard dose PPI* twice daily for 10-14 days",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <p>",
"     &nbsp;",
"    </p>",
"    <div class=\"footnotes\">",
"     <em>",
"      H. pylori",
"     </em>",
"     :",
"     <em>",
"      Helicobacter pylori",
"     </em>",
"     ; PPI: proton pump inhibitor.",
"     <br>",
"      * Lansoprazole 30 mg twice daily, omeprazole 20 mg twice daily, pantoprazole 40 mg twice daily, or rabeprazole 20 mg twice daily.",
"      <br>",
"       <font class=\"bullet\">",
"        &bull;",
"       </font>",
"       Eradication rates of 70 to 85 percent.",
"       <br>",
"        &Delta; Eradication rates of 75 to 90 percent.",
"        <br>",
"         <font class=\"lozenge\">",
"          &loz;",
"         </font>",
"         A combination preparation of bismuth subcitrate-metronidazole-tetracycline is available in the United States (trade name Pylera).",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Table adapted from data published in: Chey WD, Wong BCY. American College of Gastroenterology Guideline on the Management of",
"     <em>",
"      Helicobacter pylori",
"     </em>",
"     Infection. Am J Gastroenterol 2007; 102:1808.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_49_19228=[""].join("\n");
var outline_f18_49_19228=null;
var title_f18_49_19229="Heparin protocol I";
var content_f18_49_19229=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F66081%7EPULM%2F72792&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F66081%7EPULM%2F72792&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Example of a non-weight-based intravenous heparin protocol: Part I",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Initial intravenous heparin bolus: 5000 units.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Continuous intravenous heparin infusion: commence at 42 mL/hour of 20,000 units (1680 units/hour) in 500 mL of two-thirds dextrose and one-third saline (a 24-hour heparin dose of 40,320 units), except in the following patients, in whom heparin infusion will be commenced at a rate of 31 mL/hour (1240 units/hour) (ie, a 24-hour dose of 29,760 units).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Patients who have undergone surgery within the previous two weeks.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Patients with a previous history of peptic ulcer disease, gastrointestinal or genitourinary bleeding.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Patients with (thrombotic) stroke within the previous two weeks.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Patients with a platelet count &lt;150,000/microL.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Patients with miscellaneous reasons for a high risk of bleeding (eg, hepatic failure, renal failure, or vitamin K deficiency).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Heparin dose adjusted using the aPTT. The aPTT is performed in all patients as outlined below:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        4 to 6 hours after commencing heparin; the heparin dose is then adjusted according to the nomogram shown in Heparin Protocol-II until the aPTT is within the therapeutic range.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Thereafter, the aPTT will be performed once daily. If the value is outside the therapeutic range, the heparin dose is then adjusted according to the nomogram shown in Heparin Protocol-II until the aPTT is within the therapeutic range.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Hull RD, Raskob GE, Rosenbloom D, et al. Optimal therapeutic level of heparin therapy in patients with venous thrombosis. Arch Intern Med 1992; 152:1589.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Example of a non-weight-based intravenous heparin protocol: Part II titration based upon the activated partial thromboplastin time",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"4\" width=\"25%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"4\">",
"        IV infusion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        aPTT",
"       </td>",
"       <td class=\"subtitle2\">",
"        Rate change, mL/hour*",
"       </td>",
"       <td class=\"subtitle2\">",
"        Dose change, units/24-hour",
"       </td>",
"       <td class=\"subtitle2\">",
"        Additional action",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &le;45",
"       </td>",
"       <td>",
"        +6",
"       </td>",
"       <td>",
"        +5760",
"       </td>",
"       <td>",
"        Repeated aPTT",
"        <sup>",
"         &bull;",
"        </sup>",
"        in 4 to 6 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        46 to 54",
"       </td>",
"       <td>",
"        +3",
"       </td>",
"       <td>",
"        +2880",
"       </td>",
"       <td>",
"        Repeated aPTT in 4 to 6 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        55 to 85",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        None",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        86 to 110",
"       </td>",
"       <td>",
"        -3",
"       </td>",
"       <td>",
"        -2880",
"       </td>",
"       <td>",
"        Stop heparin sodium treatment for 1 hour; repeated aPTT 4 to 6 hours after restarting heparin treatment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &gt;110",
"       </td>",
"       <td>",
"        -6",
"       </td>",
"       <td>",
"        -5760",
"       </td>",
"       <td>",
"        Stop heparin treatment for 1 hour; repeated aPTT 4 to 6 hours after restarting heparin treatment",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    NOTE: This table reflects the original aPTT ranges, bolus sizes, and suggested changes in infusion rate that were present at the time this study was performed. The therapeutic ranges (ie, relationship between the aPTT and anti-factor Xa activity), initial and subsequent bolus sizes, and sizes of the infusion rate changes, as well as dosing differences depending on the disorder under treatment (eg, venous thromboembolism, stroke, acute coronary syndrome) should be established separately for each institution.",
"    <div class=\"footnotes\">",
"     aPTT: activated partial thromboplastin time; IV: intravenous.",
"     <br/>",
"     * Heparin sodium concentration, 20,000 units in 500 mL = 40 units/mL.",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     With the use of Actin-FS thromboplastin reagent (Dade, Mississauga, Ontario).",
"     <br/>",
"     &Delta; During the first 24 hours, repeated aPTT in 4 to 6 hours. Thereafter, the aPTT will be determined once daily, unless subtherapeutic.",
"    </div>",
"    <div class=\"reference\">",
"     Redrawn from: Hull RD, Raskob GE, Rosenbloom D, et al. Optimal therapeutic level of heparin therapy in patients with venous thrombosis. Arch Intern Med 1992; 152:1589.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_49_19229=[""].join("\n");
var outline_f18_49_19229=null;
var title_f18_49_19230="Estrogen products";
var content_f18_49_19230=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F78136&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F78136&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Some estrogen products",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1\">",
"            Drug",
"           </td>",
"           <td class=\"subtitle1\">",
"            Available strengths",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_left\" colspan=\"2\">",
"            Estrogen preparations and doses for the management of vasomotor symptoms",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle3_left\" colspan=\"2\">",
"            Oral estradiol*&bull;",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Estrace (Warner Chilcot)",
"           </td>",
"           <td>",
"            0.5, 1, 2 mg",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Gynodiol (Fielding)",
"           </td>",
"           <td>",
"            0.5, 1, 1.5, 2 mg",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle3_left\" colspan=\"2\">",
"            Oral esterified estrogen pill*&bull;",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Menest (Monarch)",
"           </td>",
"           <td>",
"            0.3, 0.625, 1.25, 2.5 mg",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Ogen (Pharmacia)&bull;",
"           </td>",
"           <td>",
"            0.75, 1.5, 3 mg estropipate (equivalent to 0.625, 1.25, 2.5 mg conjugated equine estrogen)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Ortho-Est (Women First Healthcare)&bull;",
"           </td>",
"           <td>",
"            0.75, 1.5 mg estropipate (equivalent to 0.625, 1.25 mg conjugated equine estrogen)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle3_left\" colspan=\"2\">",
"            Oral conjugated equine estrogen (CEE)*",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Premarin (Wyeth-Ayerst)",
"           </td>",
"           <td>",
"            0.3, 0.45, 0.625, 0.9, 1.25 mg",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle3_left\" colspan=\"2\">",
"            Oral conjugated synthetic estrogens*",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Cenestin (Elan)",
"           </td>",
"           <td>",
"            0.3, 0.45, 0.625, 0.9, 1.25 mg",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Enjuvia (Elan)",
"           </td>",
"           <td>",
"            0.625, 1.25 mg",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle3_left\" colspan=\"2\">",
"            Oral estrogen-progestin combinations",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Prempro&Delta; (Wyeth-Ayerst)",
"           </td>",
"           <td>",
"            0.3 mg CEE/1.5 mg medroxyprogesterone, 0.45/1.5 mg, 0.625/2.5 mg, 0.625/5 mg",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Prefest (Duramed)",
"           </td>",
"           <td>",
"            1 mg estradiol/0.9 mg norgestimate",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Activella (Novo Nordisk)",
"           </td>",
"           <td>",
"            1 mg estradiol/0.5 mg norethindrone acetate",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            FemHRT (Warner Chilcot)",
"           </td>",
"           <td>",
"            5 mcg ethinyl estradiol/1 mg norethindrone acetate",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Angeliq (Berlex)",
"           </td>",
"           <td>",
"            1 mg estradiol/0.5 mg drosperinone",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle3_left\" colspan=\"2\">",
"            Oral estrogen-testosterone combinations*&bull;",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            EEMT (Creekwood Pharmaceutical)&bull;",
"           </td>",
"           <td>",
"            1.25 mg esterified estrogen/2.5 mg methyltestosterone",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            EEMT (Creekwood Pharmaceutical) HS&bull;",
"           </td>",
"           <td>",
"            0.625 mg esterified estrogen/1.25 mg methyltestosterone",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1\">",
"            Drug",
"           </td>",
"           <td class=\"subtitle1\">",
"            Available strengths",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle3_left\" colspan=\"2\">",
"            Estradiol patches*&bull;",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Alora (Watson)",
"           </td>",
"           <td>",
"            0.025, 0.05, 0.075, 0.1 mg/day",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Climara (Berlax)",
"           </td>",
"           <td>",
"            0.025, 0.05, 0.06, 0.075, 0.1 mg/day",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Esclim (Women First)",
"           </td>",
"           <td>",
"            0.025, 0.0375, 0.05, 0.075, 0.1 mg/day",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Estraderm (Novartis)",
"           </td>",
"           <td>",
"            0.05, 0.1 mg/day",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Vivelle (Novartis)",
"           </td>",
"           <td>",
"            0.025, 0.0375, 0.05, 0.075, 0.1 mg/day",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Menostar (Bayer)",
"           </td>",
"           <td>",
"            0.014 mg/day",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle3_left\" colspan=\"2\">",
"            Estrogen-progestin patches",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Combi-Patch (Novartis)",
"           </td>",
"           <td>",
"            0.05 mg estradiol/0.14 mg norethindrone, 0.05 mg/0.25 mg",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Climara Pro (Berlex)",
"           </td>",
"           <td>",
"            0.045 mg estradiol/0.015 mg levonorgestrel",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle3_left\" colspan=\"2\">",
"            Gel*",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            EstroGel (Solvay)",
"           </td>",
"           <td>",
"            0.75 mg estradiol per pump",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle3_left\" colspan=\"2\">",
"            Emulsion*",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Estrasorb (Novavox)",
"           </td>",
"           <td>",
"            0.025 mg estradiol/pouch",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Divigel (Upsher-Smith)",
"           </td>",
"           <td>",
"            0.25, 0.5, 1 mg estradiol/pouch",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Elestrin (Kenwood)",
"           </td>",
"           <td>",
"            0.52 mg estradiol/pump",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle3_left\" colspan=\"2\">",
"            Topical spray*",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            EvaMist (KV Pharmaceutical)",
"           </td>",
"           <td>",
"            1.5 mg estradiol/spray",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle3_left\" colspan=\"2\">",
"            Intravaginal rings*",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Femring (Warner-Chilcott)",
"           </td>",
"           <td>",
"            0.05 mg estradiol/day over&nbsp;three months",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_left\" colspan=\"2\">",
"            Vaginal estrogen preparations for treatment of genitourinary atrophy (inadequate dose to relieve vasomotor symptoms)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle3_left\" colspan=\"2\">",
"            Vaginal ring",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Estring (Pharmacia)",
"           </td>",
"           <td>",
"            0.0075 mg estradiol/day, released over&nbsp;three months",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle3_left\" colspan=\"2\">",
"            Vaginal tablet",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Vagifem (Novo Nordisk)",
"           </td>",
"           <td>",
"            10&nbsp;mcg estradiol/tablet",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle3_left\" colspan=\"2\">",
"            Vaginal cream",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Estrace (Warner-Chilcot)",
"           </td>",
"           <td>",
"            0.1 mg estradiol/gram",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Premarin (Wyeth-Ayerst)",
"           </td>",
"           <td>",
"            0.625 mg equine conjugated estrogen/gram",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * For women with an intact uterus, a progestin must be added to estrogen therapy.",
"     <br>",
"      &bull; Available generically.",
"      <br>",
"       &Delta; Also available as Premphase which contains both combination tablets and estrogen alone.",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_49_19230=[""].join("\n");
var outline_f18_49_19230=null;
var title_f18_49_19231="Keratic precipitates";
var content_f18_49_19231=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F71161&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F71161&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 482px\">",
"   <div class=\"ttl\">",
"    Keratic precipitates in granulomatous uveitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 462px; height: 303px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Keratic precipitates are deposits of leukocytes on the corneal endothelium. The cellular concretions in this picture are large. This indicates a granulomatous type inflammation, although the cellular collections are not granulomas histologically.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of James T Rosenbaum, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_49_19231=[""].join("\n");
var outline_f18_49_19231=null;
